https://www.pharmaceutical-business-review.com/news/pfizer-biontech-covid-19/ 2020-11-11T11:35:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Pfizervaccine.png https://www.pharmaceutical-business-review.com/news/tezepelumab-navigator-trial-in-severe-uncontrolled-asthma-patients-meets-primary-endpoint/ 2020-11-11T12:15:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/07/astrazeneca-hq.jpg https://www.pharmaceutical-business-review.com/news/medigen-bluewillow-sars-cov-2/ 2020-11-12T08:55:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Blue-willow.jpg https://www.pharmaceutical-business-review.com/news/sagent-pharmaceuticals-launches-phase-2-trial-to-evaluate-camostat-mesilate-for-covid-19-treatment/ 2020-11-12T10:32:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Sagent.jpg https://www.pharmaceutical-business-review.com/news/russian-sputnik-v-vaccine/ 2020-11-13T04:05:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Vaccine.jpg https://www.pharmaceutical-business-review.com/news/forma-therapeutics-sickle/ 2020-11-13T04:06:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Europe.jpg https://www.pharmaceutical-business-review.com/news/lupin-announces-fda-filing-acceptance-of-snda-for-solosec-to-treat-trichomoniasis/ 2020-11-16T12:00:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/FDA-drug-3.jpg https://www.pharmaceutical-business-review.com/news/roche-lead-pharma/ 2020-11-16T12:06:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Rochebasel.jpg https://www.pharmaceutical-business-review.com/news/astrazenecas-calquence-covid-19/ 2020-11-16T12:09:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Astra.jpg https://www.pharmaceutical-business-review.com/news/vicore-pharma-recruits-the-first-patient-in-the-phase-2-proof-of-concept-study-in-idiopathic-pulmonary-fibrosis/ 2020-11-16T12:11:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/test-214185_640-18.jpg https://www.pharmaceutical-business-review.com/news/amylyx-announces-fda-granted-orphan-drug-designation-for-amx0035-to-treat-wolfram-syndrome/ 2020-11-17T11:32:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/FDA-drug-4.jpg https://www.pharmaceutical-business-review.com/news/inovio-covid-19-vaccine-2/ 2020-11-17T11:45:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Ino.jpg https://www.pharmaceutical-business-review.com/news/merck-keytruda-breast-cancer/ 2020-11-17T11:45:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/FDA-drug-2.jpg https://www.pharmaceutical-business-review.com/news/merck-advances-phase-3-trial-for-islatravir-as-once-monthly-oral-prep-for-women-at-high-risk-for-acquiring-hiv-1/ 2020-11-17T12:11:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/test-214185_640-19.jpg https://www.pharmaceutical-business-review.com/news/moderna-announces-supply-agreement-with-uk-government-to-supply-covid-19-mrna-vaccine/ 2020-11-18T11:07:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Covidvaccine.jpg https://www.pharmaceutical-business-review.com/news/moderna-covid-19/ 2020-11-18T11:39:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Moderna.jpg https://www.pharmaceutical-business-review.com/news/cerebral-therapeutics-announces-enrolment-of-first-patient-in-phase-2b-trial-in-epilepsy/ 2020-11-18T12:16:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/laboratory-3827736_640-2.jpg https://www.pharmaceutical-business-review.com/news/viiv-healthcare-cabotegravir/ 2020-11-19T09:34:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/HIV-treatment.jpg https://www.pharmaceutical-business-review.com/news/rilzabrutinib-granted-fda-fast-track-designation-for-treatment-of-immune-thrombocytopenia/ 2020-11-19T10:58:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/FDA-drug-4.jpg https://www.pharmaceutical-business-review.com/news/fda-clears-expanded-access-ind-for-apts-phagebank-therapy-for-covid-19-related-bacterial-infections/ 2020-11-19T11:59:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/APT_Photo.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-covid-19-primary-efficacy-endpoints/ 2020-11-20T08:49:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/bristol-myers-squibbf-myokardia/ 2020-11-20T08:49:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/BMS-facility.jpg https://www.pharmaceutical-business-review.com/news/novartis-secures-exclusive-rights-for-potential-acute-respiratory-distress-syndrome-cell-therapy/ 2020-11-20T10:12:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Novar-1.jpg https://www.pharmaceutical-business-review.com/news/zymeworks-gets-ecs-orphan-drug-designation-for-zanidatamab-in-patients-with-gastric-cancer/ 2020-11-20T11:38:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/mitosis-3876669_640-1.jpg https://www.pharmaceutical-business-review.com/news/adc-therapeutics-secures-fda-priority-review-for-lonca-in-diffuse-large-b-cell-lymphoma/ 2020-11-23T11:46:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/FDA-drug-4.jpg https://www.pharmaceutical-business-review.com/news/clear-creek-bio-doses-first-patient-in-phase-2-outpatient-study-of-brequinar-to-treat-covid-19/ 2020-11-23T11:50:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/trial.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-azd1222-vaccine/ 2020-11-23T12:00:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Adeno.jpg https://www.pharmaceutical-business-review.com/news/eli-lilly-incyte/ 2020-11-23T12:02:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Lilly.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-seek-fda-eua-status-for-covid-19-vaccine/ 2020-11-24T06:51:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Pfizer-2.jpg https://www.pharmaceutical-business-review.com/news/pfizer-doses-first-participant-in-phase-3-study-evaluating-anti-tfpi-investigational-therapy/ 2020-11-24T11:25:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Pfize.jpg https://www.pharmaceutical-business-review.com/news/hifibio-partners-with-pharmsynthez-and-ibch-to-develop-and-commercialise-sars-cov-2-neutralising-antibody-in-russia/ 2020-11-24T11:55:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/covid-19-4982910_640-14.jpg https://www.pharmaceutical-business-review.com/news/gsk-rsv-maternal-candidat/ 2020-11-24T12:16:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/GSK-house.jpg https://www.pharmaceutical-business-review.com/news/city-of-hope-covid-19/ 2020-11-25T10:16:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/City-of-Hope.jpg https://www.pharmaceutical-business-review.com/news/apnimed-doses-first-patient-in-phase-2-trial-of-ad109-in-obstructive-sleep-apnea/ 2020-11-25T11:38:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/lab-3498584_640-6.jpg https://www.pharmaceutical-business-review.com/news/health-canada-clears-appili-therapeutics-for-new-phase-3-trial-to-assess-avigan-to-prevent-covid-19/ 2020-11-25T11:46:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/CovidCanada.jpg https://www.pharmaceutical-business-review.com/news/merck-oncoimmune/ 2020-11-25T12:20:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Merck-1.jpg https://www.pharmaceutical-business-review.com/news/roche-xofluza/ 2020-11-25T13:02:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Basel.jpg https://www.pharmaceutical-business-review.com/news/moderna-covid-19-2/ 2020-11-26T10:22:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/European-commission.jpg https://www.pharmaceutical-business-review.com/news/fda-defers-approval-of-daxibotulinumtoxina-for-injection-in-glabellar-lines-due-to-covid-19-related-travel-restrictions/ 2020-11-26T11:22:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/FDA-drug-3.jpg https://www.pharmaceutical-business-review.com/news/celltrion-completes-enrolment-for-global-phase-ii-clinical-trial-with-covid-19-treatment-candidate/ 2020-11-26T11:24:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Corcandidate.jpg https://www.pharmaceutical-business-review.com/news/haoma-medica-completes-first-in-human-trial-for-naquinate/ 2020-11-27T11:02:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Osteo.jpg https://www.pharmaceutical-business-review.com/news/ema-validates-application-for-tepotinib-for-treatment-of-advanced-nsclc-with-metex14-skipping-alterations/ 2020-11-27T11:10:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/mitosis-3876669_640-2.jpg https://www.pharmaceutical-business-review.com/news/telix-pharmaceuticals-acquires-swiss-german-biotechnology-company-therapharm/ 2020-11-30T11:20:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Thera.jpg https://www.pharmaceutical-business-review.com/news/dr-reddys-to-acquire-select-anti-allergy-brands-from-glenmark-in-russia-ukraine-kazakhstan-and-uzbekistan/ 2020-11-30T11:29:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Dr._Reddys_Finished_Dosage_Facility_III.jpg https://www.pharmaceutical-business-review.com/news/biogen-drug-sage-therapeutics/ 2020-11-30T13:56:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Depression.jpg https://www.pharmaceutical-business-review.com/news/astellas-anaemia-evrenzo/ 2020-12-01T05:00:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Kidney.jpg https://www.pharmaceutical-business-review.com/news/zymeworks-gets-fda-breakthrough-therapy-status-for-her2-targeted-bispecific-antibody-zanidatamab-in-patients-with-btc/ 2020-12-01T10:10:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Immune-1.jpg https://www.pharmaceutical-business-review.com/uncategorized/sab-biotherapeutics-awarded-57-5m-from-barda-and-us-department-of-defense-for-sab-185/ 2020-12-01T11:41:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/covid-19-4982910_640-15.jpg https://www.pharmaceutical-business-review.com/news/neoimmunetech-covid-19/ 2020-12-01T11:43:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Immune.jpg https://www.pharmaceutical-business-review.com/news/vertex-symkevi-kalydeco/ 2020-12-01T11:44:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/11/Euro-Comm.jpg https://www.pharmaceutical-business-review.com/news/moderna-covid-19-vaccine-2/ 2020-12-02T07:06:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Moderna.jpg https://www.pharmaceutical-business-review.com/news/boston-scientific-signs-agreement-to-divest-btg-specialty-pharmaceuticals-business/ 2020-12-02T10:31:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Boston.jpg https://www.pharmaceutical-business-review.com/news/dr-reddys-and-rdif-commence-clinical-trials-for-sputnik-v-vaccine-in-india/ 2020-12-02T10:37:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/04/Dr._Reddys_Finished_Dosage_Facility_III.jpg https://www.pharmaceutical-business-review.com/news/amgen-takeda-covid-19/ 2020-12-03T08:40:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Take.jpg https://www.pharmaceutical-business-review.com/news/eli-lilly-announces-650000-additional-doses-of-bamlanivimab-purchased-by-us-government-to-treat-covid-19/ 2020-12-03T10:26:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Eli-Lilly.jpg https://www.pharmaceutical-business-review.com/news/roche-gets-fda-approval-of-gavreto-in-advanced-or-metastatic-ret-mutant-and-ret-fusion-positive-thyroid-cancers/ 2020-12-03T11:30:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2019/10/Rochebuild.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech/ 2020-12-04T10:46:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/appili-announces-dosing-of-first-patient-in-phase-3-covid-19-trial/ 2020-12-04T10:46:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Appili.jpg https://www.pharmaceutical-business-review.com/news/neurogene-announces-ema-grants-orphan-drug-designation-for-aaspartylglucosaminuria-gene-therapy/ 2020-12-04T12:00:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/FDA-drug.jpg https://www.pharmaceutical-business-review.com/news/janssen-hemera-eye/ 2020-12-07T07:14:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Human.jpg https://www.pharmaceutical-business-review.com/news/syros-acquires-clinical-stage-drug-candidate-for-acute-promyelocytic-leukemia/ 2020-12-07T10:40:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Phar.jpg https://www.pharmaceutical-business-review.com/news/sinovac-covid-19-vaccine/ 2020-12-08T07:31:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Sinovac.jpg https://www.pharmaceutical-business-review.com/news/pfizer-sangamo-announce-updated-results-of-phase-1-2-alta-study-of-giroctocogene-fitelparvovec/ 2020-12-08T12:10:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/cybin-signs-agreement-to-acquire-adelia-therapeutics/ 2020-12-08T12:14:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/CBY.jpg https://www.pharmaceutical-business-review.com/news/inovio-covid-19-vaccine-3/ 2020-12-09T08:06:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Inovio.jpg https://www.pharmaceutical-business-review.com/news/piramal-pharma-solutions-invests-32m-to-expand-riverview-michigan-facility/ 2020-12-09T11:37:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/headache-1540220_640.jpg https://www.pharmaceutical-business-review.com/news/biocryst-announces-325m-of-funding-from-royalty-pharma-and-athyrium-capital-management/ 2020-12-09T11:42:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/conclusion-of-the-contract-3100563_640.jpg https://www.pharmaceutical-business-review.com/news/amgen-sotorasib-nsclc/ 2020-12-10T07:28:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Amgen.jpg https://www.pharmaceutical-business-review.com/news/novartis-kisqali-demonstrates-nearly-five-years-median-os-in-metastatic-breast-cancer/ 2020-12-10T11:40:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/novartis-building-pnd.jpg https://www.pharmaceutical-business-review.com/news/thermo-fisher-scientific-further-expands-global-footprint-for-drug-product-development-and-commercial-manufacturing/ 2020-12-10T11:43:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/1154px-Thermo_Fisher_headquarters.jpg https://www.pharmaceutical-business-review.com/news/canada-approves-bnt162b2-covid-19/ 2020-12-11T07:07:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Pfizerworldheadquartersentrance.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-azd1222-vaccine-efficacy/ 2020-12-11T07:07:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/cq5dam.web_.1200.CGI-Aerial-View.jpg https://www.pharmaceutical-business-review.com/news/gilead-sciences-to-acquire-myr/ 2020-12-11T11:26:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/shaking-hands-3091906_640-1.jpg https://www.pharmaceutical-business-review.com/news/european-chmp-adopts-positive-opinion-for-dynavaxs-heplisav-b-vaccine-for-hepatitis-b/ 2020-12-11T11:34:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/syringe-4544448_640.jpg https://www.pharmaceutical-business-review.com/news/pfizer-and-biontech-celebrate-historic-first-authorisation-in-us-of-vaccine-to-prevent-covid-19/ 2020-12-14T10:47:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Pfizer-1.jpg https://www.pharmaceutical-business-review.com/news/merck-gets-positive-chmp-opinion-for-keytruda-as-first-line-treatment-for-dmmr-colorectal-cancer/ 2020-12-14T11:07:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-nbe-therapeutics/ 2020-12-14T11:10:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/1200px-Siedziba_Boehringer_Ingelheim_w_Polsce.jpg https://www.pharmaceutical-business-review.com/news/eureka-therapeutics-announces-preclinical-results-of-invisimask-human-antibody-nasal-spray-against-sars-cov-2-infection/ 2020-12-15T10:42:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Eurek.jpg https://www.pharmaceutical-business-review.com/news/moderna-confirms-agreement-with-singapore-for-supply-of-mrna-vaccine-against-covid-19/ 2020-12-15T10:54:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/virus-5768628_640.jpg https://www.pharmaceutical-business-review.com/news/acceleron-sotatercept-pah/ 2020-12-15T11:08:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/EC-building.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-alexion-pharmaceuticals/ 2020-12-15T11:09:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Astra.jpg https://www.pharmaceutical-business-review.com/news/novartis-leqvio-hypercholesterolemia/ 2020-12-15T11:10:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Novar.jpg https://www.pharmaceutical-business-review.com/news/eli-lilly-prevail-therapeutics/ 2020-12-16T09:30:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Eli.jpg https://www.pharmaceutical-business-review.com/news/xentria-announces-fda-orphan-drug-designation-for-xtmab-16-in-sarcoidosis/ 2020-12-16T10:45:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/FDA-drug-1.jpg https://www.pharmaceutical-business-review.com/news/cn-bio-university-of-melbourne-collaborate-to-advance-therapies-for-respiratory-complications-in-recovered-covid-19-patients/ 2020-12-16T11:08:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/covid-19-4922384_640.jpg https://www.pharmaceutical-business-review.com/news/eqt-ix-recipharm/ 2020-12-16T11:17:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Recipharm.jpg https://www.pharmaceutical-business-review.com/news/neurogene-closes-115m-series-b-financing/ 2020-12-17T10:28:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/pill.jpg https://www.pharmaceutical-business-review.com/news/merck-reports-positive-results-for-keytruda-lenvima-combo-in-phase-3-keynote-775-study-309-trial/ 2020-12-17T10:41:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2018/11/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/fsd-pharma-fsd201/ 2020-12-18T08:16:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/FSD-pharma.jpg https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-to-keytruda-for-treatment-of-esophageal-and-gastroesophageal-junction-cancer/ 2020-12-18T11:30:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/Keytruda.jpg https://www.pharmaceutical-business-review.com/news/moderna-receives-fda-advisory-committee-vote-supporting-emergency-use-for-modernas-vaccine-against-covid-19-in-us/ 2020-12-18T11:34:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Corvirus.jpg https://www.pharmaceutical-business-review.com/news/eib-launches-e50m-africa-pharmaceutical-manufacturing-initiative/ 2020-12-21T11:03:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/7d50f58a-4515-42e1-a3f0-56716a3f2916.jpg https://www.pharmaceutical-business-review.com/news/lilly-to-begin-pragmatic-study-of-bamlanivimab-for-covid-19-in-new-mexico/ 2020-12-21T11:06:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Eli.jpg https://www.pharmaceutical-business-review.com/news/gsk-active-lupus-nephritis/ 2020-12-22T08:53:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/GSK-house.jpg https://www.pharmaceutical-business-review.com/news/pfizer-and-biontech-receive-authorisation-in-european-union-for-covid-19-vaccine/ 2020-12-22T11:30:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Pfizer-2.jpg https://www.pharmaceutical-business-review.com/news/servier-agios-oncology/ 2020-12-23T08:29:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Servier.jpg https://www.pharmaceutical-business-review.com/news/moderna-covid-19-mrna-1273-fda-eua/ 2020-12-23T08:29:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/coronavirus-4833616_640.jpg https://www.pharmaceutical-business-review.com/news/hyundai-bioscience-develops-injection-drug-for-potential-treatment-of-severe-cases-of-covid-19/ 2020-12-23T10:24:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Hyund.jpg https://www.pharmaceutical-business-review.com/news/merck-announces-supply-agreement-with-us-for-initial-doses-of-investigational-biological-therapy-to-treat-covid-19/ 2020-12-24T10:13:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Merck.jpg https://www.pharmaceutical-business-review.com/news/roche-phesgo-breast-cancer-2/ 2020-12-24T10:15:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Rochebasel.jpg https://www.pharmaceutical-business-review.com/news/hepion-pharmaceuticals-covid-19/ 2020-12-24T10:16:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Herma.jpg https://www.pharmaceutical-business-review.com/news/modag-initiates-first-in-patient-phase-1b-trial-for-anle138b-in-parkinsons-disease/ 2020-12-24T11:17:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/test-214185_640.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-covid-19-2/ 2020-12-29T13:19:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Pfizer-3.jpg https://www.pharmaceutical-business-review.com/news/aurobindo-covaxx-deal-covid-19-vaccine-ub-612/ 2020-12-30T17:55:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/covid-19-4982910_640.jpg https://www.pharmaceutical-business-review.com/news/novartis-cadent-therapeutics/ 2021-01-04T04:24:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/Novartis.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-amphastars-generic-drug-hypoglycemia/ 2021-01-04T13:22:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/diabetes-2424105_640.jpg https://www.pharmaceutical-business-review.com/news/india-gives-restricted-emergency-use-approval-for-two-covid-19-vaccines/ 2021-01-05T08:35:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/test-tube-5065426_640.jpg https://www.pharmaceutical-business-review.com/news/moderna-south-korea-doses-covid-19-vaccine/ 2021-01-05T08:35:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/12/syringe-4544448_640-1.jpg https://www.pharmaceutical-business-review.com/news/fda-grants-arx788-fast-track-designation-for-her2-positive-metastatic-breast-cancer/ 2021-01-05T10:05:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/FDA-drug.jpg https://www.pharmaceutical-business-review.com/news/israeli-ministry-of-health-authorises-covid-19-vaccine-moderna-for-use-in-israel/ 2021-01-05T11:15:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/syringe-5873159_640.jpg https://www.pharmaceutical-business-review.com/news/cure-pharmaceutical-receives-fda-approval-for-ind-application-for-erectile-dysfunction-product-curefilm-blue/ 2021-01-06T11:09:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/FDA-drug-1.jpg https://www.pharmaceutical-business-review.com/news/lakepharma-akston-biosciences-covid-19/ 2021-01-06T11:15:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Zarvaccine.jpg https://www.pharmaceutical-business-review.com/news/angelini-pharma-arvelle-therapeutics/ 2021-01-06T11:15:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Arvelli.jpg https://www.pharmaceutical-business-review.com/news/moderna-covid-19-mrna-vaccine/ 2021-01-07T11:52:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/modernavaccine.jpg https://www.pharmaceutical-business-review.com/news/roche-tiragolumab-tecentriq-nsclc/ 2021-01-07T11:53:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Roche-office.jpg https://www.pharmaceutical-business-review.com/news/xencor-md-anderson-enter-collaboration-to-develop-novel-t-cell-engaging-bispecific-antibodies-for-potential-treatment-of-cancer/ 2021-01-07T11:56:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/shaking-hands-3091906_640-5.jpg https://www.pharmaceutical-business-review.com/news/redhill-biopharmas-rhb-204-granted-fda-fast-track-designation-for-ntm-disease/ 2021-01-07T11:59:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/FDA-drug-2.jpg https://www.pharmaceutical-business-review.com/news/inversago-pharma-receives-rare-paediatric-disease-designation-from-fda-for-inv-101-to-treat-prader-willi-syndrome/ 2021-01-08T10:29:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/FDA-drug-3.jpg https://www.pharmaceutical-business-review.com/news/am-pharma-covid-19/ 2021-01-08T10:34:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/AM-Pharma.jpg https://www.pharmaceutical-business-review.com/news/fujifilm-cell-culture-us/ 2021-01-08T10:35:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Fuji.jpg https://www.pharmaceutical-business-review.com/news/teva-medincell-announce-positive-results-for-registration-trial-of-tv-46000-mdc-irm-for-patients-with-schizophrenia/ 2021-01-08T11:20:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/1200px-TevaCanada7.jpg https://www.pharmaceutical-business-review.com/news/celularity-and-gx-acquisition-announce-merger-agreement-to-create-publicly-listed-leader-in-allogeneic-cellular-therapy/ 2021-01-11T10:44:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Cellular.jpg https://www.pharmaceutical-business-review.com/news/bayer-curevac-covid-19/ 2021-01-11T10:52:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Bayer.jpg https://www.pharmaceutical-business-review.com/news/pfizer-bnt162b2-vaccine-new-covid-strains/ 2021-01-11T10:53:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/1200px-Pfizer_World_Headquarters_Entrance.jpg https://www.pharmaceutical-business-review.com/news/gsk-mmv-filing-for-kozenis-in-paediatric-populations-with-p-vivax-malaria-accepted-by-australian-tga/ 2021-01-11T11:08:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/701px-GlaxoSmithKline_building_London_30_July_2007_cropped.jpg https://www.pharmaceutical-business-review.com/news/beigene-announces-collaboration-with-novartis-to-develop-and-commercialize-anti-pd-1-antibody-tislelizumab/ 2021-01-12T11:07:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/09/novartis-building-pnd.jpg https://www.pharmaceutical-business-review.com/news/rocket-pharmaceuticals-announces-buildout-of-rd-and-manufacturing-facility-to-support-development-of-gene-therapy-pipeline/ 2021-01-12T11:14:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Rock.jpg https://www.pharmaceutical-business-review.com/news/covid-19-vaccine-sputnik-v-phase-2-trial-india/ 2021-01-12T11:20:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/vaccination-1215279_640.jpg https://www.pharmaceutical-business-review.com/news/affinivax-maps-vaccine/ 2021-01-12T11:21:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Vaccine.jpg https://www.pharmaceutical-business-review.com/news/sanofi-to-buy-biopharmaceutical-firm-kymab-for-up-to-1-45bn/ 2021-01-13T09:13:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Sanofi.jpg https://www.pharmaceutical-business-review.com/news/amneal-to-acquire-substantially-all-of-kashiv-specialty-pharmaceuticals/ 2021-01-13T10:58:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/amneal.jpg https://www.pharmaceutical-business-review.com/news/bayer-announces-fda-accepts-nda-and-grants-priority-review-for-finerenone-for-patients-with-ckd-and-t2d/ 2021-01-13T11:16:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Leverkusen_Kaiser-Wilhelm-Allee_0004.jpg https://www.pharmaceutical-business-review.com/news/novartis-ligelizumab-urticaria/ 2021-01-15T08:06:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Nova.jpg https://www.pharmaceutical-business-review.com/news/ksq-takeda-immuno-oncology-therapies/ 2021-01-15T08:07:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/692px-Takeda-Midosuji-Bldg-01.jpg https://www.pharmaceutical-business-review.com/news/gsk-vir-covid-19/ 2021-01-15T08:08:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/GSK.jpg https://www.pharmaceutical-business-review.com/news/pfizers-xalkori-approved-by-fda-for-alk-positive-anaplastic-large-cell-lymphoma-in-children-and-young-adults/ 2021-01-15T10:33:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/newamsterdam-pharma-completes-196m-series-a-funding-for-phase-3-development-programme/ 2021-01-15T10:54:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/conclusion-of-the-contract-3100563_640-1.jpg https://www.pharmaceutical-business-review.com/news/thermo-fisher-scientific-acquires-viral-vector-business-from-novasep-for-875m/ 2021-01-18T11:24:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Thermo-Fisher1.jpg https://www.pharmaceutical-business-review.com/news/dr-reddys-receives-approval-to-conduct-phase-3-clinical-trial-for-sputnik-v-vaccine-in-india/ 2021-01-18T11:39:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/virus-4937553_640.jpg https://www.pharmaceutical-business-review.com/news/imfinzi-approved-in-the-eu-for-less-frequent-fixed-dose-use-in-unresectable-non-small-cell-lung-cancer/ 2021-01-18T12:33:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/1024px-AstraZeneca_HQ_in_Cambridge_UK.jpg https://www.pharmaceutical-business-review.com/news/cure-genetics-boehringer-develop-aav-vectors-gene-therapy/ 2021-01-19T10:41:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Cure-Genetics.jpg https://www.pharmaceutical-business-review.com/news/etana-launch-innovent-biologics-cancer-drug-byvasda-indonesia/ 2021-01-19T12:23:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Innovent.jpg https://www.pharmaceutical-business-review.com/news/gritstone-advancing-covid-19-vaccine-plans-trials/ 2021-01-20T12:08:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Gritstone.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-vaccine-in-vitro-study/ 2021-01-21T07:47:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/covid-19-vaccine-5902833_640.jpg https://www.pharmaceutical-business-review.com/news/novartis-gsk-genetic-diversity-research-africa/ 2021-01-21T13:48:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Novartis.jpg https://www.pharmaceutical-business-review.com/news/uae-approves-sputnik-v-vaccine-combat-covid-19/ 2021-01-22T06:45:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/RDIF.jpg https://www.pharmaceutical-business-review.com/news/akron-biotech-to-exclusively-manufacture-human-ab-serum-for-octapharma/ 2021-01-22T07:00:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Akron-Biotech.jpg https://www.pharmaceutical-business-review.com/news/humanigen-gains-barda-access-produce-lenzilumab/ 2021-01-25T09:37:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Humanigen.jpg https://www.pharmaceutical-business-review.com/news/merck-discontinues-covid-19-vaccine-candidates/ 2021-01-26T06:27:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Merck_office_Upper_Gwynedd_Township_Montgomery_County.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-china-approval-mild-asthma-symbicort-turbuhaler/ 2021-01-27T08:33:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Astrazeneca.jpg https://www.pharmaceutical-business-review.com/news/us-dod-fund-humanetics-new-drug-against-covid-19/ 2021-01-27T10:29:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Humanetics.jpg https://www.pharmaceutical-business-review.com/news/existing-drug-offers-targeted-treatment-for-aggressive-breast-cancer/ 2021-01-28T09:45:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Institute-of-Cancer-Research.jpg https://www.pharmaceutical-business-review.com/news/sanofi-manufacture-pfizer-biontechs-covid-19-vaccine/ 2021-01-28T11:55:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/Sanofi-1.jpg https://www.pharmaceutical-business-review.com/news/nih-study-severe-covid-19-pregnancy-complications/ 2021-01-29T10:38:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/NIH.jpg https://www.pharmaceutical-business-review.com/news/ge-researchers-study-covid-19-impact-lungs/ 2021-02-01T11:54:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/01/GEHealthcare.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-authorisation-covid-19-vaccine-europe/ 2021-02-03T08:16:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/AstraZeneca.jpg https://www.pharmaceutical-business-review.com/news/ocugen-distribution-bharat-biotechs-covid-19-vaccine-in-us/ 2021-02-03T10:49:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/Ocugen.jpg https://www.pharmaceutical-business-review.com/news/lilly-antibody-therapies-treating-covid-19/ 2021-02-03T14:08:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/Lily.jpg https://www.pharmaceutical-business-review.com/news/wuxi-sta-buy-facility-bristol-myers-squibb/ 2021-02-03T14:10:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/Bristol-Myers-Squibb.jpg https://www.pharmaceutical-business-review.com/news/gsk-curevac-collaboration-next-gen-covid-19-vaccines/ 2021-02-04T09:26:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/injection-5722329_1280-2.jpg https://www.pharmaceutical-business-review.com/news/johnson-johnson-eua-application-covid-19-vaccine/ 2021-02-08T10:05:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/virus-5768628_1280-1.jpg https://www.pharmaceutical-business-review.com/news/usfda-breyanzi-car-t-cell-therapy-adults/ 2021-02-08T10:39:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/1440px-Mantle_cell_lymphoma_-_intermed_mag-1.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-signs-loi-idt-biologika-boost-europes-covid-19-vaccine-making-capability/ 2021-02-11T10:39:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/vaccine-5895477_1280.jpg https://www.pharmaceutical-business-review.com/news/usfda-approves-eua-bamlanivimab-etesevimab-combo-treat-covid-19-patients/ 2021-02-11T10:42:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/coronavirus-4914026_1280.jpg https://www.pharmaceutical-business-review.com/news/usfda-approves-libtayo-skin-cancer/ 2021-02-11T10:44:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/1552px-Melanoma.jpg https://www.pharmaceutical-business-review.com/news/sandoz-to-acquire-glaxosmithklines-cephalosporin-antibiotics-business/ 2021-02-12T11:40:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/pill-1884775_1280.jpg https://www.pharmaceutical-business-review.com/news/oxford-university-commences-trial-on-covid-19-vaccine-on-children/ 2021-02-15T05:55:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/Oxford-Vaccine-Uk-Children.jpg https://www.pharmaceutical-business-review.com/news/celltrion-healthcare-ec-authorisation-yuflyma/ 2021-02-16T08:45:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/1280px-View_of_Schuman_Roundabout.jpg https://www.pharmaceutical-business-review.com/news/johnson-johnson-eu-covid-19-vaccine/ 2021-02-17T09:08:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/PBR.jpg https://www.pharmaceutical-business-review.com/news/novartis-expanded-fda-indication-label-entresto/ 2021-02-17T15:35:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/PBR-2.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-200-million-covid-19-vaccine/ 2021-02-18T09:17:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/PBR-1.jpg https://www.pharmaceutical-business-review.com/news/glaxosmithkline-vir-biotechnology-covid-19-partnership/ 2021-02-18T15:55:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/PBR-2-1.jpg https://www.pharmaceutical-business-review.com/news/usfda-grants-ftd-to-efanesoctocog-alfa-for-hemophilia-a-treatment/ 2021-02-19T10:50:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/Assorted-pills-by-JOSHUA-COLEMAN-on-Unspl-e1613730343956.jpg https://www.pharmaceutical-business-review.com/news/dynavax-marketing-authorisation-hepatitis-b-vaccine/ 2021-02-22T08:52:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/1280px-Belgique_-_Bruxelles_-_Schuman_-_Berlaymont_-_01.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-imfinzi-indication-bladder-cancer/ 2021-02-23T08:43:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/PBR-3.jpg https://www.pharmaceutical-business-review.com/news/usfda-priority-review-pfizers-ticovac/ 2021-02-24T08:45:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/PBR-1-1.jpg https://www.pharmaceutical-business-review.com/news/ucb-partnership-microsoft-drug-development/ 2021-02-24T16:02:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/PBR-2-2.jpg https://www.pharmaceutical-business-review.com/news/viiv-seeks-usfda-approval-expand-cabenuva/ 2021-02-25T15:31:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/PBR-1-2.jpg https://www.pharmaceutical-business-review.com/news/merck-signs-agreement-to-purchase-pandion-therapeutics/ 2021-02-26T09:53:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/Merck_office_Upper_Gwynedd_Township_Montgomery_County.jpg https://www.pharmaceutical-business-review.com/news/ema-pfizer-opkos-somatrogon-marketing-application/ 2021-03-01T09:13:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/PBR.jpg https://www.pharmaceutical-business-review.com/news/moderna-global-covid-19-vaccine-capacity/ 2021-03-01T16:10:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/PBR-2-3.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-gubra-peptides-obesity/ 2021-03-02T08:52:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/PBR-1.jpg https://www.pharmaceutical-business-review.com/news/deals/wuxi-apptec-oxgene-cell-gene-therapy-services/ 2021-03-03T10:20:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/shaking-hands-3091906_640.jpg https://www.pharmaceutical-business-review.com/news/merck-supply-covid-19-medicines-vaccines/ 2021-03-03T12:44:26+00:00 https://www.pharmaceutical-business-review.com/news/takeda-secures-global-rights-to-develop-and-commercialise-soticlestat/ 2021-03-04T08:51:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/medicine-257349_1280.jpg https://www.pharmaceutical-business-review.com/news/bharat-biotechs-phase-iii-interim-results-of-covaxin-demonstrate-efficacy-of-81/ 2021-03-04T18:18:42+00:00 https://www.pharmaceutical-business-review.com/news/deals/amgen-acquire-five-prime-therapeutics-1-9bn/ 2021-03-05T08:37:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/pill-4897529_1280.jpg https://www.pharmaceutical-business-review.com/news/johnson-johnsons-covid-19-vaccine-authorisation-canada/ 2021-03-08T09:02:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/PBR-2.jpg https://www.pharmaceutical-business-review.com/news/lilly-biolojic-antibody-therapies-diabetes/ 2021-03-09T09:21:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/PBR-3.jpg https://www.pharmaceutical-business-review.com/news/enveric-biosciences-signs-licensing-agreement-with-diverse-biotech/ 2021-03-11T07:55:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/Cannabis-by-David-Gabri%C4%87-on-Unsplash.jpg https://www.pharmaceutical-business-review.com/news/niaid-grants-2-5m-to-12-institutes-for-bacteriophage-therapy-research/ 2021-03-12T08:50:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/Bacterial-colonies-by-Adrian-Lange-on-Unsplash.jpg https://www.pharmaceutical-business-review.com/news/takeda-submits-new-drug-application-for-lanadelumab-in-japan/ 2021-03-15T08:52:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/Takeda-injection-by-Diana-Polekhina-on-Unsplash.jpg https://www.pharmaceutical-business-review.com/news/gilead-merck-agreement-to-develop-hiv-treatments-lenacapavir-and-islatravir/ 2021-03-16T05:53:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/Physician-and-patient-by-National-Cancer-Institute-on-Unsplash.jpg https://www.pharmaceutical-business-review.com/news/usfda-grants-priority-review-to-mercks-nda-for-hif-2%ce%b1-inhibitor-belzutifan/ 2021-03-17T06:40:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/Kidney-by-Robina-Weermeijer-on-Unsplash.jpg https://www.pharmaceutical-business-review.com/news/contracts/astrazeneca-to-deliver-500000-more-doses-of-azd7442-to-the-us/ 2021-03-17T14:13:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/Covid019-vaccination-by-Steven-Cornfield-on-Unsplash.jpg https://www.pharmaceutical-business-review.com/news/usfda-extends-review-period-for-abbvies-snda-of-upadacitinib/ 2021-03-18T07:54:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/cristina-gottardi-q3FihXQ-13M-unsplash.jpg https://www.pharmaceutical-business-review.com/news/ambrx-gets-orphan-drug-designation-gastric-cancer-treatment-arx788/ 2021-03-18T15:04:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/Orphan-drug-by-Anastasiia-Ostapovych-on-Unsplash.jpg https://www.pharmaceutical-business-review.com/news/deals/boston-pharmaceuticals-signs-three-year-agreement-with-gsk/ 2021-03-19T08:20:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/Pharma-by-Laurynas-Mereckas-on-Unsplash.jpg https://www.pharmaceutical-business-review.com/news/anima-signs-new-strategic-collaboration-deal-with-takeda/ 2021-03-19T13:45:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/Anima-by-national-Cancer-institute-on-Unsplash.jpg https://www.pharmaceutical-business-review.com/news/usfda-approves-janssens-ponvory-for-treatment-of-multiple-sclerosis/ 2021-03-22T08:24:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/Mutiple-sclerosis-by-Matteo-Badini-on-Unsplash.jpg https://www.pharmaceutical-business-review.com/news/dyadic-medytox-co-develop-covid-19-variant-fighting-vaccines/ 2021-03-23T08:19:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/Covid-vaccine-by-Macau-Photo-Agency-on-Unsplash.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-zealand-pharmas-zegalogue-for-hypoglycemia-treatment/ 2021-03-23T14:35:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/Hypoglycemia-by-Diabetesmagazijn.nl-on-Unsplash.jpg https://www.pharmaceutical-business-review.com/news/fidia-farmaceutici-sanofis-anti-inflammatory-drugs/ 2021-03-24T09:12:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/PBR-4.jpg https://www.pharmaceutical-business-review.com/news/ucla-led-lab-study-identifies-potential-drug-to-treat-sars-cov-2-virus/ 2021-03-25T10:42:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/corona-5174671_1280.jpg https://www.pharmaceutical-business-review.com/news/us-nih-sars-cov-2-virus-infects-cells-mouth/ 2021-03-26T09:18:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/20210325-mouth.jpg https://www.pharmaceutical-business-review.com/news/ema-gilead-sciences-breast-cancer-therapy/ 2021-03-26T13:40:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/1280px-Vivaldigebouw_2019.10.24_1.jpg https://www.pharmaceutical-business-review.com/news/japan-bristol-myers-squibbs-b-cell-lymphoma/ 2021-03-26T13:47:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/1440px-Mantle_cell_lymphoma_-_intermed_mag.jpg https://www.pharmaceutical-business-review.com/news/usfda-abecma-relapsed-refractory-multiple-myeloma/ 2021-03-29T08:18:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/national-cancer-institute-lTlB51-XGP4-unsplash.jpg https://www.pharmaceutical-business-review.com/news/usfda-sends-crl-to-mercks-sbla-regarding-keytruda/ 2021-03-30T08:19:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/Breast-cancer-by-Angiola-Harry-on-Unsplash.jpg https://www.pharmaceutical-business-review.com/news/amgen-biopharmaceutical-rodeo-therapeutics/ 2021-03-31T08:52:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/1533px-Amgenheadquarters.jpg https://www.pharmaceutical-business-review.com/news/takeda-otc-non-core-assets-orifarm/ 2021-04-01T09:03:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/shaking-hands-3091906_1280.jpg https://www.pharmaceutical-business-review.com/news/piramal-apis-hemmo-pharmaceuticals/ 2021-04-01T10:23:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/50999907705_389c784bde_k.jpg https://www.pharmaceutical-business-review.com/news/abbvie-usfda-review-period-rinvoq-snda/ 2021-04-05T09:01:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/2474512963_5583007b7c_k.jpg https://www.pharmaceutical-business-review.com/news/anixa-and-ontochem-enter-next-stage-of-covid-19-anti-viral-therapy-development/ 2021-04-06T07:47:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/martin-sanchez-VhjsGKMefkk-unsplash-1.jpg https://www.pharmaceutical-business-review.com/news/antengene-nmpa-approval-ind-atg-019/ 2021-04-06T09:08:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/national-cancer-institute-QMmKpJ557iQ-unsplash.jpg https://www.pharmaceutical-business-review.com/news/ab-science-university-of-chicago-covid-19-treatment/ 2021-04-07T10:15:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/2880px-University_of_Chicago_July_2013_19_Main_Quadrangles.jpg https://www.pharmaceutical-business-review.com/news/usfda-eli-lilly-incytes-snda-baricitinib/ 2021-04-07T15:11:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/2880px-Eli_Lilly_Corporate_Center_Indianapolis_Indiana_USA.jpg https://www.pharmaceutical-business-review.com/news/abbvie-presents-applications-to-fda-and-ema-for-approval-of-skyrizi-in-psoriatic-arthritis/ 2021-04-08T07:39:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/steven-hwg-zBsdRTHIIm4-unsplash.jpg https://www.pharmaceutical-business-review.com/news/deals/sanofi-acquires-tidal-therapeutics/ 2021-04-12T08:59:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/michael-schiffer-13UugSL9q7A-unsplash.jpg https://www.pharmaceutical-business-review.com/news/airway-therapeutics-ind-application-at-100-covid-19/ 2021-04-13T09:00:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/Coronavirus-13-April-2021.jpg https://www.pharmaceutical-business-review.com/news/biogen-and-bio-thera-solutions-announce-commercialisation-and-license-agreement-for-bat1806/ 2021-04-13T09:04:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/board-4862180_1920.jpg https://www.pharmaceutical-business-review.com/news/dr-reddys-secures-eua-for-sputnik-v-in-india/ 2021-04-14T07:02:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/coronavirus-5935581_1920.jpg https://www.pharmaceutical-business-review.com/news/trodelvy-granted-accelerated-approval-by-usfda-for-metastatic-urothelial-cancer/ 2021-04-14T14:36:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/doctor-5707722_1920.jpg https://www.pharmaceutical-business-review.com/news/scineuro-and-eli-lilly-sign-exclusive-license-agreement-for-alpha-synuclein-in-greater-china/ 2021-04-15T07:09:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/jesse-orrico-rmWtVQN5RzU-unsplash.jpg https://www.pharmaceutical-business-review.com/news/european-commission-grants-bristol-myers-squibb-approval-for-opdivo-to-treat-rcc/ 2021-04-15T22:42:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/national-cancer-institute-sbW1T0Yfz8k-unsplash.jpg https://www.pharmaceutical-business-review.com/news/gsk-and-vir-announce-ema-review-of-vir-7831-for-early-treatment-of-covid-19/ 2021-04-16T09:13:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/virus-4931227_1920.jpg https://www.pharmaceutical-business-review.com/news/us-clearance-granted-for-astrazenecas-proposed-acquisition-of-alexion/ 2021-04-19T09:08:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/check-3183195_1920.jpg https://www.pharmaceutical-business-review.com/news/second-indication-of-sarclisa-for-relapsed-multiple-myeloma-approved-by-ec/ 2021-04-20T08:12:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/anton-oemojNQYYe4-unsplash.jpg https://www.pharmaceutical-business-review.com/news/johnson-johnson-to-resume-covid-19-vaccine-roll-out-in-europe-after-ema-review/ 2021-04-21T09:08:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/steven-cornfield-NtVFMrMmxWY-unsplash.jpg https://www.pharmaceutical-business-review.com/news/claritas-cmax-clinical-phase-1-r-107-clinical-study/ 2021-04-22T12:07:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/national-cancer-institute-fOLO2hDMsa4-unsplash.jpg https://www.pharmaceutical-business-review.com/news/vertex-obsidian-partner-gene-editing-medicines/ 2021-04-23T08:26:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/NIH.jpg https://www.pharmaceutical-business-review.com/news/study-parp-inhibitors-kill-cancer-cells-pbrm1-gene/ 2021-04-26T09:54:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/patient-and-clinician_945x532.jpg https://www.pharmaceutical-business-review.com/news/emas-chmp-eu-astrazeneca-mercks-selumetinib/ 2021-04-27T10:44:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/original.jpg https://www.pharmaceutical-business-review.com/news/merck-licences-indian-companies-molnupiravir/ 2021-04-28T08:00:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/test-tube-5065426_1280.jpg https://www.pharmaceutical-business-review.com/news/pfizer-acquires-amplyx-pharmaceuticals/ 2021-04-29T09:00:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/shaking-hands-3091906_1280-1.jpg https://www.pharmaceutical-business-review.com/news/canbridge-mirum-maralixibat-greater-china/ 2021-04-30T10:54:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/04/document-428334_1280.jpg https://www.pharmaceutical-business-review.com/news/who-emergency-use-modernas-covid-19-vaccine/ 2021-05-03T09:23:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/syringe-5873159_1280.jpg https://www.pharmaceutical-business-review.com/news/revive-ucsf-bucillamine-severe-covid-19/ 2021-05-04T08:03:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/coronavirus-5086678_1280.jpg https://www.pharmaceutical-business-review.com/news/viiv-rolling-submission-cabotegravir-prevent-hiv/ 2021-05-05T08:33:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/hiv-1903371_1280.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-covid-19-vaccine-canada-approval-for-adolescents/ 2021-05-06T07:31:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/vaccine-6158184_1280.jpg https://www.pharmaceutical-business-review.com/news/russia-single-dose-covid-19-vaccine-sputnik-light/ 2021-05-07T08:19:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/vaccine-6109246_1280.jpg https://www.pharmaceutical-business-review.com/news/dr-reddys-license-anti-bcma-car-t-prg1801-india/ 2021-05-14T03:32:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/nurse-4967171_1280.jpg https://www.pharmaceutical-business-review.com/news/fda-pfizer-biontech-vaccine-adolescents/ 2021-05-14T03:38:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/vaccinate-4833616_1280.jpg https://www.pharmaceutical-business-review.com/news/japans-takeda-to-acquire-the-us-maverick-therapeutics/ 2021-05-14T03:39:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/03/Photo-by-National-Cancer-Institute-on-Unsplash-e1615360017290.jpg https://www.pharmaceutical-business-review.com/news/usfda-breakthrough-therapy-designation-novartis-asciminib/ 2021-05-14T03:40:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/02/jar-2338584_1280.jpg https://www.pharmaceutical-business-review.com/news/lilly-mina-therapeutics-drug-candidates/ 2021-05-14T03:41:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/1024px-Eli_Lilly_Corporate_Center_Indianapolis_Indiana_USA.jpg https://www.pharmaceutical-business-review.com/news/indias-dcgi-oxygen-dependence-lowering-covid-19-drug/ 2021-05-14T03:42:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/coronavirus-4932607_1280.jpg https://www.pharmaceutical-business-review.com/news/dr-reddys-pilot-russias-sputnik-v-vaccine-india/ 2021-05-17T08:01:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/vaccine-5895477_1280-2.jpg https://www.pharmaceutical-business-review.com/news/charles-river-acquire-vigene-biosciences/ 2021-05-18T08:56:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/dna-3889611_1280.jpg https://www.pharmaceutical-business-review.com/news/bms-cancer-therapy-deal-agenus/ 2021-05-20T05:37:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/4353113087_4d19c3a402_c.jpg https://www.pharmaceutical-business-review.com/news/exscientia-bms-deal/ 2021-05-20T07:44:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/AI-2005.jpg https://www.pharmaceutical-business-review.com/news/gsk-sells-stake-innoviva-392m/ 2021-05-21T11:25:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/GSK.jpg https://www.pharmaceutical-business-review.com/news/japan-astrazeneca-modernas-covid-19-vaccines/ 2021-05-24T08:46:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/vaccinate-4833616_1280-1.jpg https://www.pharmaceutical-business-review.com/news/xeris-pharmaceuticals-strongbridge-biopharma/ 2021-05-25T08:32:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/shaking-hands-3091906_1280.jpg https://www.pharmaceutical-business-review.com/news/pieris-genentech-respiratory-ophthalmology-therapies/ 2021-05-26T08:50:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/hand-3632914_1280.jpg https://www.pharmaceutical-business-review.com/news/carlyle-acquire-vectura-for-1-4bn/ 2021-05-27T13:22:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/conclusion-of-the-contract-3100563_1280.jpg https://www.pharmaceutical-business-review.com/news/prestige-consumer-healthcare-akorns-brands-230m/ 2021-05-28T07:12:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/eye-2340806_1280.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-covid-19-vaccine-eu-authorisation/ 2021-05-31T07:41:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/virus-5768628_1280.jpg https://www.pharmaceutical-business-review.com/news/samsung-biologics-mrna-vaccine-production-line/ 2021-06-01T08:44:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/20210531180621Baa63092e-ae4c-4262-ad18-c3b065dc7e5c.jpg https://www.pharmaceutical-business-review.com/news/amgen-kyowa-kirin-antibody-atopic-dermatitis/ 2021-06-02T09:15:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/1533px-Amgenheadquarters.jpg https://www.pharmaceutical-business-review.com/news/morphosys-constellation-pharmaceuticals-1-7bn/ 2021-06-03T09:48:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/sw7-mor_0263_0.jpg https://www.pharmaceutical-business-review.com/news/centivax-collaboration-us-nmrc-covid-19-antibody/ 2021-06-03T13:35:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/vaccine-5926664_1280.jpg https://www.pharmaceutical-business-review.com/news/merck-completion-organon-spinoff/ 2021-06-04T09:03:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/KW.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-covid-19-vaccine-uk-approval/ 2021-06-07T08:54:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/hakan-nural-Z2n-r7pg6kM-unsplash.jpg https://www.pharmaceutical-business-review.com/news/biogen-eisai-fda-alzheimers-drug-aduhelm/ 2021-06-08T09:03:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/mental-3436232_1280.jpg https://www.pharmaceutical-business-review.com/news/indivior-aelis-cannabis-use-disorder/ 2021-06-09T09:39:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/seedling-1062908_1280.jpg https://www.pharmaceutical-business-review.com/news/merck-1-7-million-courses-molnupiravir-us/ 2021-06-10T09:29:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/KW-1.jpg https://www.pharmaceutical-business-review.com/news/ocugen-approval-covaxin-us/ 2021-06-11T09:48:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/vaccinate-4833616_1280.jpg https://www.pharmaceutical-business-review.com/news/emas-chmp-modernas-covid-19-vaccine/ 2021-06-14T08:05:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/virus-5768628_1280.jpg https://www.pharmaceutical-business-review.com/news/gsk-iteos-therapeutics-co-develop-cancer-drug/ 2021-06-15T07:37:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/mitosis-3876669_1280.jpg https://www.pharmaceutical-business-review.com/news/mallinckrodt-fda-approval-stratagraft/ 2021-06-16T08:09:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/StrataGraft-scaled.jpg https://www.pharmaceutical-business-review.com/news/novartis-prostate-cancer-drug-breakthrough-status/ 2021-06-17T09:58:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/Novartis_1706.jpg https://www.pharmaceutical-business-review.com/news/danaher-acquire-aldevron-9-6bn/ 2021-06-18T07:58:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/microbiology-1806.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-belgium-court-vaccine-doses-eu/ 2021-06-21T08:54:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/vaccine-5926664_1280-1.jpg https://www.pharmaceutical-business-review.com/news/arrowhead-horizon-collaboration-rnai-therapeutic/ 2021-06-22T08:51:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/shaking-hands-3091906_1280.jpg https://www.pharmaceutical-business-review.com/news/european-commission-modernas-covid-19-vaccine/ 2021-06-23T07:41:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/vaccine-5942321_1280.jpg https://www.pharmaceutical-business-review.com/news/viiv-halozyme-develop-hiv-medicines/ 2021-06-23T12:13:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/hiv-1903373_1280.jpg https://www.pharmaceutical-business-review.com/news/gsk-plans-consumer-healthcare-spin-off/ 2021-06-24T08:34:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/GSK-2406.jpg https://www.pharmaceutical-business-review.com/news/eisai-biogen-alzheimers-drug-breakthrough-status/ 2021-06-24T09:21:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/beta-amyloid.jpg https://www.pharmaceutical-business-review.com/news/fda-emergency-use-actemra-covid/ 2021-06-25T06:53:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/Roche-2506.jpg https://www.pharmaceutical-business-review.com/news/abbvie-acquire-teneoone-lead-drug/ 2021-06-25T10:42:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/AbbVieUSE.jpg https://www.pharmaceutical-business-review.com/news/johnson-johnson-230m-settle-opioid-claims/ 2021-06-28T08:08:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/jar-2338584_1280.jpg https://www.pharmaceutical-business-review.com/news/stada-sanofis-consumer-healthcare-brands/ 2021-06-29T09:04:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/20210628_press_release_stada_further_grows_european_consumer_healthcare_portfolio_609x571.jpg https://www.pharmaceutical-business-review.com/news/sanofi-mrna-center-of-excellence-covid-19-vaccines/ 2021-06-30T08:46:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/06/virus-5768628_1280-1.jpg https://www.pharmaceutical-business-review.com/news/gic-invests-1bn-grifols-biomat-usa/ 2021-07-01T09:21:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/plasma-2753321_1280.jpg https://www.pharmaceutical-business-review.com/news/ifc-713m-aspen-covid-19-vaccine/ 2021-07-01T13:15:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/vaccine-6109246_1280.jpg https://www.pharmaceutical-business-review.com/news/philip-morris-acquire-fertin-pharma-812-8m/ 2021-07-02T09:18:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/shaking-hands-3091906_1280.jpg https://www.pharmaceutical-business-review.com/news/seres-nestle-oral-microbiome-therapeutic-canada-us/ 2021-07-02T14:49:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/Clostridium_difficile_colonies.jpg https://www.pharmaceutical-business-review.com/news/gsk-alector-antibodies-neurodegenerative-diseases/ 2021-07-05T09:04:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/brain-1787622_1280.jpg https://www.pharmaceutical-business-review.com/news/mexico-produces-sputnik-v-covid-19-vaccine/ 2021-07-06T09:56:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/coronavirus-5935581_1280.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-clearance-alexion-acquisition/ 2021-07-07T10:52:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/original.jpg https://www.pharmaceutical-business-review.com/news/eureka-msk-license-agreement-sanofi-gprc5d-binder/ 2021-07-07T13:41:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/mitosis-3876669_1280.jpg https://www.pharmaceutical-business-review.com/news/altesa-license-agreement-vaxart-vapendavir/ 2021-07-08T09:13:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/8405362662_a5f2951f27_c.jpg https://www.pharmaceutical-business-review.com/news/us-fda-grants-priority-review-to-tezepelumab-to-treat-asthma-patients/ 2021-07-08T14:50:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/original-1.jpg https://www.pharmaceutical-business-review.com/news/verge-genomics-eli-lilly-develop-als-therapies/ 2021-07-09T09:04:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/Alice_1.jpg https://www.pharmaceutical-business-review.com/news/philip-morris-vectura-group-1-2bn/ 2021-07-12T08:46:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/17-07-24_pmi_day05_09722.jpg https://www.pharmaceutical-business-review.com/news/novo-nordisk-prothenas-attr-amyloidosis-programme/ 2021-07-13T08:52:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/conclusion-of-the-contract-3100563_1280.jpg https://www.pharmaceutical-business-review.com/news/rdif-sii-sputnik-v-covid-19-vaccine-india/ 2021-07-14T09:26:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/daniel-schludi-ZeMRI9vO71o-unsplash.jpg https://www.pharmaceutical-business-review.com/news/prime-medicine-315m-funding-editing-platform/ 2021-07-14T13:41:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/gout-2870583_1280.jpg https://www.pharmaceutical-business-review.com/news/lilly-remaining-shares-protomer-technologies/ 2021-07-15T09:58:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/1440px-Eli_Lilly_Corporate_Center_Indianapolis_Indiana_USA.jpg https://www.pharmaceutical-business-review.com/news/regeneron-1-8bn-expand-research-facilities/ 2021-07-16T09:32:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/1440px-New_Eastview_office_bldg_jeh.jpg https://www.pharmaceutical-business-review.com/news/gsk-biotech-life-sciences-campus-stevenage/ 2021-07-19T09:50:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/GlaxoSmithKline_building_London_30_July_2007_cropped.jpg https://www.pharmaceutical-business-review.com/news/partners-group-pharmathen-bc-partners-1-9bn/ 2021-07-20T09:21:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/pill-1884775_1280.jpg https://www.pharmaceutical-business-review.com/news/japan-roches-ronapreve-covid-19-treatment/ 2021-07-21T08:59:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/towfiqu-barbhuiya-FsVEqeiOtPo-unsplash.jpg https://www.pharmaceutical-business-review.com/news/three-us-drug-distributors-1-18bn-opioid-cas/ 2021-07-21T14:00:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/national-cancer-institute-2g9uIMeVKvk-unsplash.jpg https://www.pharmaceutical-business-review.com/news/biovac-pfizer-biontech-covid-19-vaccine/ 2021-07-22T09:20:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/hakan-nural-yzrH-RZwios-unsplash.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-acquisition-biopharmaceutical-firm-alexion/ 2021-07-22T13:04:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/original-2.jpg https://www.pharmaceutical-business-review.com/news/pfizer-and-arvinas-to-jointly-develop-and-commercialise-breast-cancer-drug/ 2021-07-23T09:45:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/national-cancer-institute-W2OVh2w2Kpo-unsplash.jpg https://www.pharmaceutical-business-review.com/news/fda-keytruda-lenvima-combination-endometrial-cancer/ 2021-07-23T13:12:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/1434px-Endometrial_adenocarcinoma_1.jpg https://www.pharmaceutical-business-review.com/news/emas-chmp-eu-modernas-covid-19-vaccine/ 2021-07-26T09:51:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/vaccine-6165772_1280.jpg https://www.pharmaceutical-business-review.com/news/perkinelmer-acquire-life-science-antibodies-biolegend/ 2021-07-27T08:15:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/1540px-PerkinElmer_headquarters.jpg https://www.pharmaceutical-business-review.com/news/amgen-acquire-biotechnology-firm-teneobio/ 2021-07-28T08:19:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/Thousand-Oaks_CA_10.jpg https://www.pharmaceutical-business-review.com/news/abbvie-calico-age-related-disease-therapies/ 2021-07-28T12:35:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/AbbVieHQE_004.jpg https://www.pharmaceutical-business-review.com/news/gsk-vir-biotechnology-covid-19-drug-eu/ 2021-07-29T08:49:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/22720111227_2a042d40c2_k.jpg https://www.pharmaceutical-business-review.com/news/deep-genomics-180m-ai-platform-rna-therapies/ 2021-07-29T13:04:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/dna-4068826_1280.jpg https://www.pharmaceutical-business-review.com/news/usfda-baricitinib-emergency-use-covid-19-patients/ 2021-07-30T09:00:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/1440px-Eli_Lilly_Corporate_Center_Indianapolis_Indiana_USA-1.jpg https://www.pharmaceutical-business-review.com/news/takeda-frazier-hillevax-norovirus-vaccine/ 2021-07-30T13:18:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/07/syringe-5904302_1280.jpg https://www.pharmaceutical-business-review.com/news/usfda-regen-cov-post-exposure-prophylaxis/ 2021-08-02T09:19:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/mufid-majnun-cM1aU42FnRg-unsplash.jpg https://www.pharmaceutical-business-review.com/news/ipsen-exicure-co-develop-neurodegenerative-diseases/ 2021-08-03T09:17:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/fakurian-design-58Z17lnVS4U-unsplash.jpg https://www.pharmaceutical-business-review.com/news/sanofi-mrna-partner-translate-bio/ 2021-08-04T09:12:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/shaking-hands-3091906_1280.jpg https://www.pharmaceutical-business-review.com/news/amgen-drug-substance-manufacturing-plant/ 2021-08-04T13:06:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/Flag_TO_042.jpg https://www.pharmaceutical-business-review.com/news/european-buy-200-million-novavax-covid-19-vaccine/ 2021-08-05T09:04:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/daniel-schludi-ZeMRI9vO71o-unsplash.jpg https://www.pharmaceutical-business-review.com/news/bayer-vividion-therapeutic-for-1-5bn/ 2021-08-05T13:49:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/1440px-Leverkusen_Kaiser-Wilhelm-Allee_0004.jpg https://www.pharmaceutical-business-review.com/news/nih-study-enrolment-brii-biosciences-covid-19-antibodies/ 2021-08-06T08:51:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/corona-5174671_1920.jpg https://www.pharmaceutical-business-review.com/news/akston-dosing-phase-ii-trial-covid-19-vaccine/ 2021-08-06T08:53:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/vaccine-5926664_1920.jpg https://www.pharmaceutical-business-review.com/news/india-approves-jjs-single-dose-covid-19-vaccine/ 2021-08-09T09:09:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/vaccine-5895477_1920.jpg https://www.pharmaceutical-business-review.com/news/inovio-covid-19-vaccine-prime-boost-trials-china/ 2021-08-10T09:45:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/virus-5768628_1280-3.jpg https://www.pharmaceutical-business-review.com/news/moderna-mrna-vaccine-manufacturing-canada/ 2021-08-11T09:05:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/ian-hutchinson-iuiKtPNHObA-unsplash.jpg https://www.pharmaceutical-business-review.com/news/usfda-priority-review-mercks-keytruda/ 2021-08-11T13:22:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/robina-weermeijer-szKjHyPq28-unsplash.jpg https://www.pharmaceutical-business-review.com/news/fda-astrazeneca-fibrogens-roxadustat-ckd-anaemia/ 2021-08-12T08:24:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/original.jpg https://www.pharmaceutical-business-review.com/news/gentibio-157m-series-a-funding-round/ 2021-08-12T13:27:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/allergy-1738191_1280.jpg https://www.pharmaceutical-business-review.com/news/usfda-covid-19-vaccine-doses-weak-immune-systems/ 2021-08-13T09:39:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/covid-19-vaccine-5902833_1280.jpg https://www.pharmaceutical-business-review.com/news/modernas-covid-19-vaccine-antibodies-variants/ 2021-08-13T13:38:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/vaccine-6165772_1280.jpg https://www.pharmaceutical-business-review.com/news/merck-rolling-submission-molnupiravir-covid-19-patients/ 2021-08-16T09:01:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/KW.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-data-covid-19-booster-authorisation/ 2021-08-17T10:39:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/jesse-paul-z5Bx31kQ2Pw-unsplash.jpg https://www.pharmaceutical-business-review.com/news/gritstone-cepi-covid-19-vaccine/ 2021-08-18T08:29:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/49679608341_f1aba40db1_k.jpg https://www.pharmaceutical-business-review.com/news/aurinia-two-pipeline-autoimmune-kidney-diseases/ 2021-08-18T14:08:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/pills-3673645_1280.jpg https://www.pharmaceutical-business-review.com/news/us-fda-boehringer-eli-lilly-jardiance/ 2021-08-19T07:35:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/48710782226_966417d9e7_h.jpg https://www.pharmaceutical-business-review.com/news/somalogic-twist-bioscience-novel-antibodies/ 2021-08-19T14:29:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/virus-5741636_1280.jpg https://www.pharmaceutical-business-review.com/news/nice-midostaurin-advanced-systemic-mastocytosis/ 2021-08-20T10:27:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/red-blood-cell-4256710_1280.jpg https://www.pharmaceutical-business-review.com/news/ec-bristol-myers-anti-bcma-car-t-cell-treatment/ 2021-08-23T08:47:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/vaccination-2722937_1280.jpg https://www.pharmaceutical-business-review.com/news/india-eua-zydus-cadilas-zycov-d-covid-19/ 2021-08-23T08:49:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/ZyCov-D-packshot.jpg https://www.pharmaceutical-business-review.com/news/us-fda-pfizer-biontechs-covid-19-vaccine/ 2021-08-24T09:20:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/covid-19-vaccine-5902833_1280-1.jpg https://www.pharmaceutical-business-review.com/news/european-commission-rinvoq-atopic-dermatitis/ 2021-08-25T10:29:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/33151969262_80181b4028_k.jpg https://www.pharmaceutical-business-review.com/news/roche-collaboration-licence-agreement-roche/ 2021-08-26T08:42:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/roche-5-e1629887248429.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-fda-covid-19-booster-dose/ 2021-08-26T09:23:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/vaccinate-4833616_1280.jpg https://www.pharmaceutical-business-review.com/news/lilly-lycia-lytac-degraders-development/ 2021-08-26T13:32:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/1440px-Eli_Lilly_Corporate_Center_Indianapolis_Indiana_USA.jpg https://www.pharmaceutical-business-review.com/news/japan-approve-astrazenecas-forxiga/ 2021-08-27T07:35:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/AstraZeneca_HQ-27th-Aug.jpg https://www.pharmaceutical-business-review.com/news/inovio-covid-vaccine-brazil/ 2021-08-27T10:45:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/research-2708.jpg https://www.pharmaceutical-business-review.com/news/roche-us-tecentriq-breast-cancer/ 2021-08-30T09:57:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/national-cancer-institute-W2OVh2w2Kpo-unsplash.jpg https://www.pharmaceutical-business-review.com/news/us-fda-ucbs-briviact/ 2021-08-31T10:02:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/08/syringe-1884784_1280.jpg https://www.pharmaceutical-business-review.com/news/senhwa-dmc-approval-phase-ii-trial-silmitasertib/ 2021-09-01T08:50:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/medications-257336_640.jpg https://www.pharmaceutical-business-review.com/news/us-fda-teva-medincells-schizophrenia/ 2021-09-01T14:05:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/brain-1787622_1280.jpg https://www.pharmaceutical-business-review.com/news/merck-ridgeback-covid-19-antiviral/ 2021-09-02T09:04:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/Covid-19.jpg https://www.pharmaceutical-business-review.com/news/moderna-submission-covid-19-booster-dose/ 2021-09-02T12:10:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/Coronavirus.jpg https://www.pharmaceutical-business-review.com/news/sobi-takeover-advent-gic/ 2021-09-03T08:33:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/Sobi.jpg https://www.pharmaceutical-business-review.com/news/fda-fast-track-designation-novartis-lna043/ 2021-09-03T11:12:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/Knee.jpg https://www.pharmaceutical-business-review.com/news/reliance-dcgi-approval-phase-i-covid-19-vaccine-trial/ 2021-09-06T08:54:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/reliance-vaccine.jpg https://www.pharmaceutical-business-review.com/news/ema-booster-dose-pfizer-biontech/ 2021-09-07T07:17:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/Vaccination.jpg https://www.pharmaceutical-business-review.com/news/adaptimmune-genentech-allogeneic-cell-therapies/ 2021-09-09T04:41:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/cells-0909.jpg https://www.pharmaceutical-business-review.com/news/aim-application-ampligen-covid-19/ 2021-09-09T08:17:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/Covid-19-pill.jpg https://www.pharmaceutical-business-review.com/news/us-fda-declines-humanigens-eua-covid-19-lenzilumab/ 2021-09-10T05:35:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/coronavirus-6557675_640.jpg https://www.pharmaceutical-business-review.com/news/engeneic-covid-vaccine/ 2021-09-10T07:10:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/vaccine.jpg https://www.pharmaceutical-business-review.com/news/uks-mhra-sotorasib-lung-cancer/ 2021-09-13T10:17:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/national-cancer-institute-59pGROkKJPE-unsplash.jpg https://www.pharmaceutical-business-review.com/news/azurrx-first-wave-bio-229m/ 2021-09-14T08:59:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/shaking-hands-3091906_1280.jpg https://www.pharmaceutical-business-review.com/news/sanofi-mrna-therapies-firm-translate-bio/ 2021-09-15T10:12:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/syringe-1884784_1280.jpg https://www.pharmaceutical-business-review.com/news/regeneron-1-4-million-additional-regen-cov-doses/ 2021-09-15T16:32:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/hand-6276264_1280.jpg https://www.pharmaceutical-business-review.com/news/lilly-additional-doses-etesevimab-us/ 2021-09-16T09:49:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/1440px-Eli_Lilly_Corporate_Center_Indianapolis_Indiana_USA.jpg https://www.pharmaceutical-business-review.com/news/hookipa-merck-phase-ii-hb-200-keytruda/ 2021-09-16T12:59:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/mitosis-3876669_1280.jpg https://www.pharmaceutical-business-review.com/news/canada-moderna-pfizer-biontechs-covid-19-vaccines/ 2021-09-17T08:58:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/vaccine-6557415_1280.jpg https://www.pharmaceutical-business-review.com/news/serum-institute-life-sciences-biocon-biologics-alliance/ 2021-09-17T15:22:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/medications-257336_1280.jpg https://www.pharmaceutical-business-review.com/news/grifols-tiancheng-pharmaceutical-1-3bn/ 2021-09-20T09:09:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/shaking-hands-3091906_1280-1.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-reports-positive-results-for-covid-19-vaccine-trail-in-children-aged-5-to-11-years/ 2021-09-21T09:03:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/vaccination-1215279_1280.jpg https://www.pharmaceutical-business-review.com/news/us-fda-samsung-bioepis-biogens-byooviz/ 2021-09-21T15:30:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/visual-5028090_1280.jpg https://www.pharmaceutical-business-review.com/news/boehringer-abexxa-biologics-cancer-therapies/ 2021-09-22T09:31:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/national-cancer-institute-aelk4Tn0vlI-unsplash.jpg https://www.pharmaceutical-business-review.com/news/us-fda-pfizer-biontech-covid-19-booster-dose/ 2021-09-23T09:07:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/injection-5873159_1280.jpg https://www.pharmaceutical-business-review.com/news/abcellera-everest-medicines-discover-antibody-therapies/ 2021-09-23T13:34:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/laboratory-3827738_1280.jpg https://www.pharmaceutical-business-review.com/news/tonix-columbia-university-tailored-covid-19-vaccines/ 2021-09-24T09:38:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/vaccine-5897391_1280.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-vaxequity-self-amplifying-rna/ 2021-09-24T13:59:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/original.jpg https://www.pharmaceutical-business-review.com/news/who-regeneron-antibody-cocktail-covid-19/ 2021-09-27T09:07:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/hakan-nural-YCVUR2JgfHA-unsplash.jpg https://www.pharmaceutical-business-review.com/news/amgen-fda-repatha-paediatric-hefh/ 2021-09-27T14:31:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/27894408378_38e1cee459_k.jpg https://www.pharmaceutical-business-review.com/news/pfizer-phase-i-trial-mrna-influenza-vaccine/ 2021-09-28T09:26:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/flu-shot-1719334_1280.jpg https://www.pharmaceutical-business-review.com/news/incyte-syndax-develop-commercialise-axatilimab/ 2021-09-28T14:12:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/handshake-3100563_1280.jpg https://www.pharmaceutical-business-review.com/news/japan-astrazenecas-saphnelo-systemic-lupus-erythematosus/ 2021-09-29T09:19:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/original-1.jpg https://www.pharmaceutical-business-review.com/news/union-innovent-develop-market-orismilast/ 2021-09-30T04:21:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/33151969262_80181b4028_k.jpg https://www.pharmaceutical-business-review.com/news/appili-aipharma-avigan-reeqonus-development/ 2021-09-30T09:37:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/injection-g496774960_1280.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-acquire-caelum-biosciences/ 2021-09-30T15:50:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/09/original-2.jpg https://www.pharmaceutical-business-review.com/news/trevena-positive-results-of-trv027-covid-19/ 2021-10-01T08:47:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/corona-gadbedecac_1280.jpg https://www.pharmaceutical-business-review.com/news/merck-buy-acceleron-pharma-11-5bn/ 2021-10-01T12:30:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/KW-1.jpg https://www.pharmaceutical-business-review.com/news/kite-fda-tecartus-acute-lymphoblastic-leukemia/ 2021-10-04T11:03:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/1620px-FDA_Bldg_51_-_Main_Entrance_5161374834.jpg https://www.pharmaceutical-business-review.com/news/australia-agreement-new-covid-19-drug/ 2021-10-05T08:45:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/medicine-ga0b28755b_1280.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-fda-eua-antibody-cocktail-covid-19/ 2021-10-06T06:55:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/virus-g90c66212d_1280.jpg https://www.pharmaceutical-business-review.com/news/astrazenecas-alexion-concludes-caelum-acquisition/ 2021-10-07T09:08:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/800px-AstraZeneca_HQ_in_Cambridge_UK.jpg https://www.pharmaceutical-business-review.com/news/fda-accepts-nda-acer-reliefs-urea-cycle-disorder-therapy/ 2021-10-08T01:48:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/Tablets.jpg https://www.pharmaceutical-business-review.com/news/enzolytics-samsung-biologics-therapies-hiv-covid-19/ 2021-10-08T09:07:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/national-cancer-institute-ZeitGGtlwzI-unsplash.jpg https://www.pharmaceutical-business-review.com/news/brii-biosciences-eua-brii-196-brii-198-therapy/ 2021-10-11T10:14:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/50953231798_30e4eff0b7_k.jpg https://www.pharmaceutical-business-review.com/news/pacira-buy-flexion-therapeutics/ 2021-10-12T10:23:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/knee-g13e74aa9f_1280.jpg https://www.pharmaceutical-business-review.com/news/poseida-takeda-eight-in-vivo-gene-therapy/ 2021-10-13T11:23:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/cdc-rHCNMH9Vlmw-unsplash.jpg https://www.pharmaceutical-business-review.com/news/fda-ema-accept-novartis-beovu/ 2021-10-14T10:03:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/Diabetic_macular_edema.jpg https://www.pharmaceutical-business-review.com/news/intellia-sparingvision-develop-ocular-therapies/ 2021-10-14T12:36:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/eye-gc1c5ed892_1280.jpg https://www.pharmaceutical-business-review.com/news/exelixis-storm-novel-drug-leads-treat-cancer/ 2021-10-15T05:30:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/national-cancer-institute-fOLO2hDMsa4-unsplash.jpg https://www.pharmaceutical-business-review.com/news/silence-hansoh-novel-sirna-therapeutics/ 2021-10-18T12:39:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/laboratory-ga56586165_1280.jpg https://www.pharmaceutical-business-review.com/news/us-fdas-jj-covid-19-vaccine-booster/ 2021-10-18T15:13:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/steven-cornfield-NtVFMrMmxWY-unsplash.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-covid-19-vaccine-making-sites/ 2021-10-19T10:20:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/covid-19-vaccine-gd7a2b75c8_1280.jpg https://www.pharmaceutical-business-review.com/news/us-fda-oyster-point-pharmas-nasal-spray/ 2021-10-19T15:33:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/people-g34c941786_1280.jpg https://www.pharmaceutical-business-review.com/news/moleculin-mhra-phase-ia-wp1122-covid-19/ 2021-10-20T10:07:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/coronavirus-g7f1f35cd5_1280.jpg https://www.pharmaceutical-business-review.com/news/amgen-biotechnology-firm-teneobio/ 2021-10-20T15:46:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/Grounds_TO_051.jpg https://www.pharmaceutical-business-review.com/news/beigenes-brukinsa-mantle-cell-lymphoma/ 2021-10-21T11:26:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/Nodular_Mantle_Cell_Lymphoma_-_high_power_view_-_by_Gabriel_Caponetti.jpg https://www.pharmaceutical-business-review.com/news/ec-keytruda-chemotherapy-combination-tnbc/ 2021-10-25T11:14:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/KEYTRUDA2-1.jpg https://www.pharmaceutical-business-review.com/news/emas-rolling-review-molnupiravir-covid-19/ 2021-10-26T11:28:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/KW.jpg https://www.pharmaceutical-business-review.com/news/immunai-expand-drug-actuary-platform/ 2021-11-02T07:34:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/laboratory-g3d0caa047_1280.jpg https://www.pharmaceutical-business-review.com/news/takeda-gammadelta-allogeneic-cell-therapies/ 2021-11-02T07:46:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/shaking-hands-gcbca28405_1280.jpg https://www.pharmaceutical-business-review.com/news/teva-modag-drug-candidates-neurodegenerative/ 2021-11-02T07:46:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/1457px-MSA_aSynuclein.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biontech-covid-19-vaccine-paediatric-doses/ 2021-11-02T07:49:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/vaccine-gfd43a07d9_1280.jpg https://www.pharmaceutical-business-review.com/news/atreca-gates-mri-antibody-malaria-prevention/ 2021-11-02T07:51:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/Malaria_Parasite_Connecting_to_Human_Red_Blood_Cell_34034143483.jpg https://www.pharmaceutical-business-review.com/news/vertex-mammoth-in-vivo-gene-editing-therapies/ 2021-11-02T07:52:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/dna-g142f71882_1280.jpg https://www.pharmaceutical-business-review.com/news/fda-eua-pfizer-biontechs-covid-19-children/ 2021-11-03T10:27:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/vaccine-g7a9cecaff_1280.jpg https://www.pharmaceutical-business-review.com/news/gilead-merck-combination-therapy-breast-cancer/ 2021-11-04T02:02:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/10/national-cancer-institute-I-F4ibaAtLA-unsplash.jpg https://www.pharmaceutical-business-review.com/news/cdr-agrees-acquire-udg-healthcare/ 2021-11-04T02:02:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/05/pill-1884775_1280-1.jpg https://www.pharmaceutical-business-review.com/news/synthekine-merck-cytokine-therapies/ 2021-11-04T02:04:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/laboratory-g179b8da86_1280.jpg https://www.pharmaceutical-business-review.com/news/dunad-novartis-oral-protein-degrader-therapies/ 2021-11-04T02:04:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/myriam-zilles-KltoLK6Mk-g-unsplash.jpg https://www.pharmaceutical-business-review.com/news/stingthera-merck-snx281-combination-keytruda/ 2021-11-04T04:26:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/Lymphoma.jpg https://www.pharmaceutical-business-review.com/news/novavax-emergency-use-listing-who-covid-19/ 2021-11-05T09:45:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/vaccination-g486cc1777_1280.jpg https://www.pharmaceutical-business-review.com/news/nice-dapagliflozin-chronic-kidney-disease/ 2021-11-08T10:02:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/robina-weermeijer-szKjHyPq28-unsplash.jpg https://www.pharmaceutical-business-review.com/news/regenxbio-abbvie-deal-rgx-314/ 2021-11-10T10:53:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/eye-g225818c9d_1280.jpg https://www.pharmaceutical-business-review.com/news/arbor-biotechnologies-series-b-round/ 2021-11-11T07:40:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/liver-g5b6d97899_1280.png https://www.pharmaceutical-business-review.com/news/swissmedic-effrx-bronchitol-cystic-fibrosis/ 2021-11-11T07:42:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/medications-gdba6f1647_1280.jpg https://www.pharmaceutical-business-review.com/news/german-austrian-approve-merck-acceleron/ 2021-11-11T07:48:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/Automated-Visual-Inspection-of-Filled-Vials-1.jpg https://www.pharmaceutical-business-review.com/news/valneva-covid-19-vaccine-doses-europe/ 2021-11-11T10:59:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/vaccination-gc582b9799_1280.jpg https://www.pharmaceutical-business-review.com/news/abbvie-university-chicago-oncology-research/ 2021-11-12T11:04:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/national-cancer-institute-NbZQYileaOI-unsplash.jpg https://www.pharmaceutical-business-review.com/news/boehringer-lillys-jardiance-priority-review/ 2021-11-12T11:08:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/medicine-gf7f61b3b7_1280.jpg https://www.pharmaceutical-business-review.com/news/emas-chmp-novo-nordisks-wegovy-obesity/ 2021-11-12T14:31:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/syringe-g447c19adf_1280.jpg https://www.pharmaceutical-business-review.com/news/health-canada-moderna-covid-19-booster-shot/ 2021-11-16T10:30:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/vaccine-g2c853f270_1280.jpg https://www.pharmaceutical-business-review.com/news/pfizer-eua-covid-19-antiviral-pill-in-us/ 2021-11-17T10:18:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/tablets-gbe5b81d8b_1280.jpg https://www.pharmaceutical-business-review.com/news/ec-roche-ronapreve-covid-19-treatment/ 2021-11-17T11:10:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/towfiqu-barbhuiya-FsVEqeiOtPo-unsplash.jpg https://www.pharmaceutical-business-review.com/news/acelyrin-250m-series-b-round/ 2021-11-17T14:57:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/eye-g17e1ef8e5_1280.jpg https://www.pharmaceutical-business-review.com/news/pfizer-acquires-trillium-therapeutics/ 2021-11-18T10:32:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/pfizer-g358ad4382_1280.jpg https://www.pharmaceutical-business-review.com/news/gsk-vir-covid-19-antibody-treatment-doses/ 2021-11-19T08:08:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/22720111227_2a042d40c2_k.jpg https://www.pharmaceutical-business-review.com/news/pfizer-us-covid-19-oral-antiviral-drug-courses/ 2021-11-19T10:18:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/1592px-Pfizer_World_Headquarters_Entrance.jpg https://www.pharmaceutical-business-review.com/news/fda-expanded-eua-pfizer-biontech-covid-19-vaccine-booster-dose/ 2021-11-23T16:00:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/coronavirus-gd34042378_1280.jpg https://www.pharmaceutical-business-review.com/news/baidu-lineardesign-sanofis-product-design-pipeline/ 2021-11-23T16:00:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/vaccine-g126577dd2_1280.jpg https://www.pharmaceutical-business-review.com/news/novo-nordisk-dicerna-rnai-technology/ 2021-11-23T16:00:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/original.jpg https://www.pharmaceutical-business-review.com/news/gileads-trodelvy-ec-approval-metastatic-tnbc-treatment/ 2021-11-24T09:55:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/EC-24thNov.jpg https://www.pharmaceutical-business-review.com/news/health-canada-johnson-johnson-covid-19-vaccine/ 2021-11-25T10:14:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/mohammad-shahhosseini-AH42sxEw7ig-unsplash.jpg https://www.pharmaceutical-business-review.com/news/chmp-pfizer-biontechs-covid-19-vaccine-children/ 2021-11-26T10:17:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/vaccination-gb3ff77437_1280.jpg https://www.pharmaceutical-business-review.com/news/quell-156m-series-b-funds-cell-therapies/ 2021-11-29T10:26:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/7273434238_f1349b8ec8_o.jpg https://www.pharmaceutical-business-review.com/news/us-fda-avacta-groups-ava6000/ 2021-11-29T11:59:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/Cancer-1.jpg https://www.pharmaceutical-business-review.com/news/valneva-idt-biologika-covid-19-vaccines/ 2021-11-30T10:28:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/Untitled.jpg https://www.pharmaceutical-business-review.com/news/gilead-sciences-aws-preferred-cloud-provider/ 2021-12-01T11:42:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/11/Gilead-30thNov.jpg https://www.pharmaceutical-business-review.com/news/abbvie-ema-approval-risankizumab-skyrizi-crohns-disease/ 2021-12-01T11:43:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/stomach-pain-gf911737db_1280.jpg https://www.pharmaceutical-business-review.com/news/us-fda-priority-review-astrazenecas-snda/ 2021-12-01T11:45:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/Breast-cancer-cells.jpg https://www.pharmaceutical-business-review.com/news/sanofi-austria-origimm-biotechnology/ 2021-12-02T08:31:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/acne-gff2069a12_1280.jpg https://www.pharmaceutical-business-review.com/news/quantum-genomics-license-production-agreement-julphar/ 2021-12-06T11:12:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/tablets-Quantum.jpg https://www.pharmaceutical-business-review.com/news/ema-review-valnevas-covid-19-vaccine-vla2001/ 2021-12-06T11:13:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/vaccination-gf54d67f42_1280.jpg https://www.pharmaceutical-business-review.com/news/merck-thermo-fisher-scientific-molnupiravir/ 2021-12-07T17:38:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/tablets-Covid.jpg https://www.pharmaceutical-business-review.com/news/ema-sanofi-asmd-therapy/ 2021-12-08T14:25:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/Niemann_pick_cell_in_spleen.jpg https://www.pharmaceutical-business-review.com/news/merck-keytruda-fda-therapy-melanoma/ 2021-12-08T16:52:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/KEYTRUDA2.jpg https://www.pharmaceutical-business-review.com/news/recursion-roche-genentech-collaborate-in-neuroscience-oncology/ 2021-12-08T17:34:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/pills-g85a3ed5cf_1280.jpg https://www.pharmaceutical-business-review.com/news/allergan-availability-vuity-us-pharmacies/ 2021-12-10T17:58:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/towfiqu-barbhuiya-6F2mPewg2RA-unsplash.jpg https://www.pharmaceutical-business-review.com/news/prestige-dr-reddys-trastuzumab-biosimilar/ 2021-12-10T17:59:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/Breast_carcinoma_in_a_lymph_node.jpg https://www.pharmaceutical-business-review.com/news/arbutus-molecular-targets-covid-19/ 2021-12-10T17:59:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/51368758192_d33fc31ac8_k.jpg https://www.pharmaceutical-business-review.com/news/zealand-pharma-financing-agreement-oberland-capital/ 2021-12-15T17:16:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/pill-15Dec-2021.jpg https://www.pharmaceutical-business-review.com/news/pfizer-cibinqo-ec-atopic-dermatitis/ 2021-12-15T18:14:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/1592px-Pfizer_World_Headquarters_Entrance.jpg https://www.pharmaceutical-business-review.com/news/anheart-therapeutics-series-b-financing-round/ 2021-12-15T18:31:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/Lung.jpg https://www.pharmaceutical-business-review.com/news/agex-therapeutics-research-collaboration-with-uci/ 2021-12-15T18:31:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/Brain-model.jpg https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-immatics-solid-tumour-drug/ 2021-12-16T05:21:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/national-cancer-institute-fOLO2hDMsa4-unsplash.jpg https://www.pharmaceutical-business-review.com/news/novo-nordisk-production-facilities-danish-plant/ 2021-12-16T05:21:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/medications-ge4a00742b_1280.jpg https://www.pharmaceutical-business-review.com/news/emas-chmp-positive-opinion-pfizers-opkos-somatrogon/ 2021-12-20T10:39:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/Child-GHD.jpg https://www.pharmaceutical-business-review.com/news/alpine-immune-horizon-autoimmune-disease/ 2021-12-20T18:09:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/national-cancer-institute-Vb0GY3PWSSM-unsplash-1.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-fda-acceptance-bla-spesolimab/ 2021-12-20T18:09:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/pill-16Dec2021.jpg https://www.pharmaceutical-business-review.com/news/chmp-astrazenecas-saphnelo-treat-sle/ 2021-12-21T09:20:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/original.jpg https://www.pharmaceutical-business-review.com/news/novavax-ec-authorization-covid-19-vaccine/ 2021-12-21T14:12:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/injection-g75e8acdc0_1280.jpg https://www.pharmaceutical-business-review.com/news/fda-viiv-healthcares-apretude-hiv-prevention/ 2021-12-21T14:27:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/ApretudeVial.jpg https://www.pharmaceutical-business-review.com/news/merck-supply-1-75-million-molnupiravir-courses-uk/ 2021-12-23T09:53:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/molnupiravir-group-capsules-white.jpg https://www.pharmaceutical-business-review.com/news/pfizer-2-5-million-additional-doses-covid-19-pill-uk/ 2021-12-23T10:14:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/Covid-pill-23rdDec.jpg https://www.pharmaceutical-business-review.com/news/ambys-expand-liver-cell-therapy-production/ 2021-12-24T17:29:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/4166531944_38a2d7ec4a_h.jpg https://www.pharmaceutical-business-review.com/news/sandoz-ema-eirgenixs-trastuzumab-biosimilar/ 2021-12-27T17:29:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/national-cancer-institute-I-F4ibaAtLA-unsplash.jpg https://www.pharmaceutical-business-review.com/news/fda-novartis-cosentyx-arthritis-children-adolescents/ 2021-12-28T12:25:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/tower-with-surrounding-buildings.jpg https://www.pharmaceutical-business-review.com/news/texas-childrens-hospital-protein-covid-19-vaccine/ 2021-12-29T11:17:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/51191367706_772ddab730_k.jpg https://www.pharmaceutical-business-review.com/news/japan-keytruda-lenvima-endometrial-cancer/ 2021-12-30T13:57:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/KEYTRUDA2-1.jpg https://www.pharmaceutical-business-review.com/news/bsf-enterprise-acquire-3d-bio-tissues/ 2021-12-30T14:23:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/eye-g5353f0a8f_1280.jpg https://www.pharmaceutical-business-review.com/news/ovid-license-astrazeneca-epilepsy-drug-pipeline/ 2022-01-04T10:22:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/fire-gae9d0f335_1280.jpg https://www.pharmaceutical-business-review.com/news/ascletis-ritonavir-oral-tablets-covid-19-surge/ 2022-01-04T10:28:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/christina-victoria-craft-ZHys6xN7sUE-unsplash.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-ionis-close-deal/ 2022-01-04T10:28:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2021/12/PBR-Astra.jpg https://www.pharmaceutical-business-review.com/news/amgen-generate-protein-therapeutics/ 2022-01-07T10:19:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/Flag_TO_042.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biohaven-collaboration-agreements/ 2022-01-10T02:36:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/1592px-Pfizer_World_Headquarters_Entrance.jpg https://www.pharmaceutical-business-review.com/news/fda-breakthrough-designation-abbvie-teliso-v-nsclc/ 2022-01-10T02:36:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/AbbVieHQE_011_low.jpg https://www.pharmaceutical-business-review.com/news/absci-merck-collaborate-new-enzymes/ 2022-01-10T15:52:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/national-cancer-institute-XknuBmnjbKg-unsplash.jpg https://www.pharmaceutical-business-review.com/news/pfizer-beam-research-collaboration-rare-diseases/ 2022-01-11T10:11:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/Neurons-11Jan2022.jpg https://www.pharmaceutical-business-review.com/news/abbvie-approval-upadacitinib-nr-axspa/ 2022-01-11T10:12:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/hal-gatewood-nhG5gix93es-unsplash.jpg https://www.pharmaceutical-business-review.com/news/neogene-therapeutics-global-license-agreement-nci/ 2022-01-12T09:26:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/cells-12Jan2022.jpg https://www.pharmaceutical-business-review.com/news/lantern-pharma-nci-oncology-partnership/ 2022-01-13T11:22:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/injection-ga66f4c3f2_1280.jpg https://www.pharmaceutical-business-review.com/news/prellis-bristol-myers-squibb-discover-antibodies/ 2022-01-14T06:29:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/Untitled.jpg https://www.pharmaceutical-business-review.com/news/fda-pfizer-cibinqo-atopic-dermatitis-treatment/ 2022-01-17T09:48:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/hal-gatewood-nhG5gix93es-unsplash-1.jpg https://www.pharmaceutical-business-review.com/news/neurimmune-ono-extend-partnership/ 2022-01-18T11:34:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/josh-riemer-OH5BRdggi2w-unsplash-1-e1642504907481.jpg https://www.pharmaceutical-business-review.com/news/galapagos-jyseleca-uk-authorization/ 2022-01-19T10:52:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/danilo-alvesd-Y14ONzYtxb4-unsplash-2.jpg https://www.pharmaceutical-business-review.com/news/regeneron-fda-libtayo-with-chemotherapy-nsclc/ 2022-01-20T11:55:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/Regeneron.jpg https://www.pharmaceutical-business-review.com/news/senhwa-biosciences-odd-silmitasertib-treat-biliary-tract-cancer/ 2022-01-21T12:01:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/medications-21Jan2022.jpg https://www.pharmaceutical-business-review.com/news/fda-applied-pharmaceutical-ind-aps03118/ 2022-01-24T10:48:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/national-cancer-institute-mbL91Lg56zc-unsplash.jpg https://www.pharmaceutical-business-review.com/news/amyris-buy-womens-wellness-menolabs/ 2022-01-25T11:16:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/national-cancer-institute-NFvdKIhxYlU-unsplash.jpg https://www.pharmaceutical-business-review.com/news/twist-artisan-development-labs-discover-cell-therapies/ 2022-01-26T07:19:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/laboratory-g71a450966_1280.jpg https://www.pharmaceutical-business-review.com/news/roche-fda-priority-review-evrysdi-sma-new-borns/ 2022-01-27T11:07:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/312452.jpg https://www.pharmaceutical-business-review.com/news/ocugen-liminals-vaccine-manufacturing-facility/ 2022-01-28T09:17:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/syringe-g8f448265f_1280.jpg https://www.pharmaceutical-business-review.com/news/chmp-bristol-breyanzi-treat-lymphoma/ 2022-01-31T11:34:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/01/1440px-Bristol_Myers_Squibb_Moreton_Wirral_-_IMG_0369.jpg https://www.pharmaceutical-business-review.com/news/novavax-seeks-eua-fda-covid-19-vaccine/ 2022-02-01T09:46:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/02/mufid-majnun-cM1aU42FnRg-unsplash.jpg https://www.pharmaceutical-business-review.com/news/viiv-healthcare-fda-cabenuva-treat-hiv/ 2022-02-02T09:50:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/02/hiv-geaf7ed120_1280.jpg https://www.pharmaceutical-business-review.com/news/alvotech-biosanapharma-develop-biosimilar-xolair/ 2022-02-03T10:04:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/02/f02e5223-ea07-48cc-843b-1e6d90a6c515_Alvotech_0020_01.jpg https://www.pharmaceutical-business-review.com/news/mersana-janssen-adc-product-candidates/ 2022-02-08T16:58:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/02/laboratory-g771bbd1c9_1280.jpg https://www.pharmaceutical-business-review.com/news/nhs-drug-treat-advanced-womb-cancer/ 2022-02-09T10:31:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/02/1620px-Endometrioid_endometrial_adenocarcinoma_very_high_mag.jpg https://www.pharmaceutical-business-review.com/news/fda-sanofis-enjaymo-cold-agglutinin-disease-treatment/ 2022-02-09T10:32:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/02/1280px-Sanofi_Frankfurt_IPH.jpg https://www.pharmaceutical-business-review.com/news/healx-ovid-license-rights-develop-gaboxadol/ 2022-02-09T11:42:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/02/medications-9Feb2022.jpg https://www.pharmaceutical-business-review.com/news/seismic-101m-advance-two-drug-programmes/ 2022-02-10T09:23:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/02/science-gc7c25045f_1280.jpg https://www.pharmaceutical-business-review.com/news/adcentrx-therapeutics-avantgen-partnership-antibodies/ 2022-02-15T10:37:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/02/dna-15Feb2022.jpg https://www.pharmaceutical-business-review.com/news/us-fda-spectrum-pharmaceuticals-poziotinib/ 2022-02-15T10:37:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/02/Lung-cancer.jpg https://www.pharmaceutical-business-review.com/news/nurosene-cyclica-neurodegenerative-disease-drug/ 2022-02-15T10:38:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/02/robina-weermeijer-3KGF9R_0oHs-unsplash.jpg https://www.pharmaceutical-business-review.com/news/fda-mirati-therapeutics-nsclc-therapy/ 2022-02-16T10:25:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/02/IMG_7332.jpg https://www.pharmaceutical-business-review.com/news/swanbio-fda-fast-track-designation-adrenomyeloneuropathy/ 2022-02-17T10:19:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/02/Adrenoleukodystrophy.jpg https://www.pharmaceutical-business-review.com/news/synthego-200m-accelerate-discoveries-therapeutics/ 2022-02-18T11:04:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/02/national-cancer-institute-Vb0GY3PWSSM-unsplash.jpg https://www.pharmaceutical-business-review.com/news/dizal-fda-fast-track-designation-lymphoma/ 2022-02-21T10:38:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/02/1440px-Hodgkin_lymphoma_nodular_lymphocyte_predominant_-_high_power_view_-_HE_-_by_Gabriel_Caponetti.jpg https://www.pharmaceutical-business-review.com/news/yantai-luye-chengdu-biostar-market-anticancer-drug/ 2022-02-22T10:43:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/02/1645439088_uz5myi.jpg https://www.pharmaceutical-business-review.com/news/abbvie-snda-major-depressive-disorder-therapy/ 2022-02-23T10:16:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/02/AbbVieHQ.jpg https://www.pharmaceutical-business-review.com/news/ena-respiratory-copd-foundation-antiviral-nasal-spray/ 2022-02-24T09:43:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/02/people-gfdbb05ae5_1280.jpg https://www.pharmaceutical-business-review.com/news/boehringers-fda-breakthrough-therapy/ 2022-02-25T10:27:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/02/BI_HQ.jpg https://www.pharmaceutical-business-review.com/news/japan-keytruda-lenvima-renal-cell-carcinoma/ 2022-02-28T09:36:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/02/Untitled.png https://www.pharmaceutical-business-review.com/news/abbvie-snda-chronic-graft-versus-host-disease-therapy/ 2022-03-01T11:28:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/AbbVieUSE_054_low.jpg https://www.pharmaceutical-business-review.com/news/fda-declines-approval-gilead-sciences-hiv-treatment/ 2022-03-02T10:21:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/national-cancer-institute-cI8T6zeDbZw-unsplash.jpg https://www.pharmaceutical-business-review.com/news/ema-glaxosmithklines-maa-chronic-kidney-disease-therapy/ 2022-03-02T15:32:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/robina-weermeijer-szKjHyPq28-unsplash.jpg https://www.pharmaceutical-business-review.com/news/rondo-advance-solid-tumour-immuno-oncology-platform/ 2022-03-03T09:39:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/national-cancer-institute-Cx0LsYrM_Ns-unsplash.jpg https://www.pharmaceutical-business-review.com/news/epsilogen-antibodies-cancer-treatment-new-funding/ 2022-03-03T14:43:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/1620px-Mucinous_lmp_ovarian_tumour_intermed_mag.jpg https://www.pharmaceutical-business-review.com/news/helsinn-bridgebio-infigratinib-oncology-indications/ 2022-03-04T10:49:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/national-cancer-institute-L7en7Lb-Ovc-unsplash.jpg https://www.pharmaceutical-business-review.com/news/altamira-nuance-distribution-deal-bentrio-asian-markets/ 2022-03-07T10:26:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/people-g89f43b068_1280.jpg https://www.pharmaceutical-business-review.com/news/intellia-therapeutics-ntla-5001-aml/ 2022-03-10T10:54:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/Pills-10March2022-1.jpg https://www.pharmaceutical-business-review.com/news/janssen-mantle-cell-lymphoma-therapy/ 2022-03-10T11:04:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/Nodular_Mantle_Cell_Lymphoma_-_high_power_view_-_by_Gabriel_Caponetti.jpg https://www.pharmaceutical-business-review.com/news/salubris-funding-complex-biologics-various-diseases/ 2022-03-10T11:05:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/jesse-orrico-Us3AQvyOP-o-unsplash.jpg https://www.pharmaceutical-business-review.com/news/erasca-eli-lilly-colorectal-cancer-therapy-trial/ 2022-03-11T10:12:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/Micrograph_of_colorectal_carcinoma_with_dirty_necrosis.jpg https://www.pharmaceutical-business-review.com/news/astrazeneca-merck-fda-approval-lynparza-breast-cancer/ 2022-03-14T10:06:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/KW.jpg https://www.pharmaceutical-business-review.com/news/fda-review-period-incyte-snda-ruxolitinib-cream/ 2022-03-15T10:27:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/cream-gb427c4a63_1280.jpg https://www.pharmaceutical-business-review.com/news/phathom-nda-fda-vonoprazan-erosive-esophagitis/ 2022-03-15T12:16:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/Eosinophilic_esophagitis.jpg https://www.pharmaceutical-business-review.com/news/sanofi-blackstone-multiple-myeloma-treatment/ 2022-03-16T09:53:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/1440px-Cast_nephropathy_-_2_cropped_-_very_high_mag.jpg https://www.pharmaceutical-business-review.com/news/clovis-oncology-evergreen-actinium-225-labeled-fap-2286/ 2022-03-17T10:25:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/national-cancer-institute-fOLO2hDMsa4-unsplash.jpg https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-fda-metastatic-melanoma/ 2022-03-21T08:54:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/BMS.jpg https://www.pharmaceutical-business-review.com/news/triumvira-immunologics-funds-t-cell-therapy-programmes/ 2022-03-21T08:56:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/science-g202110b88_1280.jpg https://www.pharmaceutical-business-review.com/news/fda-merck-anti-pd-1-therapy-endometrial-carcinoma/ 2022-03-22T09:34:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/KEYTRUDA2.jpg https://www.pharmaceutical-business-review.com/news/affini-t-funding-advance-t-cell-therapies/ 2022-03-23T10:02:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/laboratory-gc4415ee53_1280.jpg https://www.pharmaceutical-business-review.com/news/lifemine-funds-advance-genomic-drug-discovery-platform/ 2022-03-24T10:11:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/sangharsh-lohakare-Iy7QyzOs1bo-unsplash.jpg https://www.pharmaceutical-business-review.com/news/fda-approve-eli-lilly-innovents-lung-cancer-treatment/ 2022-03-25T10:28:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/1620px-Squamous_carcinoma_lung_cytology.jpg https://www.pharmaceutical-business-review.com/news/roche-chmp-recommendation-combo-therapy-lymphoma/ 2022-03-28T10:04:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/1601px-Diffuse_large_B_cell_lymphoma_-_cytology_low_mag.jpg https://www.pharmaceutical-business-review.com/news/fda-ucbs-fintepla-treat-epilepsy-children/ 2022-03-29T10:25:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/child-g7c67ae835_1280.jpg https://www.pharmaceutical-business-review.com/news/axsome-therapeutics-sunosi-acquisition/ 2022-03-29T15:10:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/man-g76aaa9e8b_1280.jpg https://www.pharmaceutical-business-review.com/news/abionyx-odd-cer-001-treat-lcat-deficiency/ 2022-03-30T10:38:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/robina-weermeijer-sRXCFkJahGk-unsplash.jpg https://www.pharmaceutical-business-review.com/news/everest-nda-metastatic-breast-cancer-therapy/ 2022-03-31T10:11:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/03/national-cancer-institute-I-F4ibaAtLA-unsplash.jpg https://www.pharmaceutical-business-review.com/news/organon-license-dare-bioscience-xaciato/ 2022-04-01T11:14:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/beach-gf3ea25418_1280.jpg https://www.pharmaceutical-business-review.com/news/fda-junshi-ind-application-anti-cd112r-antibody/ 2022-04-04T10:17:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/national-cancer-institute-L7en7Lb-Ovc-unsplash.jpg https://www.pharmaceutical-business-review.com/news/vigeneron-collaboration-agreement-regeneron-pharmaceuticals/ 2022-04-07T08:00:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/dna-7April2022.jpg https://www.pharmaceutical-business-review.com/news/novartis-pik3ca-related-overgrowth-spectrum/ 2022-04-07T08:02:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/red-blood-cell-g2d108d776_1280.jpg https://www.pharmaceutical-business-review.com/news/fda-regeneron-sanofi-dupixent-priority-review/ 2022-04-07T08:03:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/1440px-New_Eastview_office_bldg_jeh.jpg https://www.pharmaceutical-business-review.com/news/harbour-biomed-astrazeneca-license-deal-bispecific-antibody/ 2022-04-08T11:11:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/Gastric_adenocarcinoma.jpg https://www.pharmaceutical-business-review.com/news/aurion-biotech-120m-cell-therapy-programme/ 2022-04-13T08:57:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/eye-13April2022.jpg https://www.pharmaceutical-business-review.com/news/ardelyx-license-deal-kyowa-kirin-for-tenapanor/ 2022-04-13T08:59:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/contract-g78195e06a_1280.jpg https://www.pharmaceutical-business-review.com/news/glenmark-dcgi-carry-out-hodgkins-lymphoma-treatment-trial/ 2022-04-13T08:59:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/1468px-Hodgkin_lymphoma_cytology_large.jpg https://www.pharmaceutical-business-review.com/news/ec-astellas-seagen-bladder-cancer-treatment/ 2022-04-14T10:30:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/4520953314_f7606f80b6_h.jpg https://www.pharmaceutical-business-review.com/news/nice-merck-tepmetko-non-small-cell-lung-cancer/ 2022-04-18T09:43:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/national-cancer-institute-zoFbfT0M_BU-unsplash.jpg https://www.pharmaceutical-business-review.com/news/asahi-kasei-medical-to-buy-bionova-scientific/ 2022-04-20T07:27:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/building.jpg https://www.pharmaceutical-business-review.com/news/biocytogen-ctm-biotech-develop-antibody-drugs/ 2022-04-21T09:32:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/virus-ga3718fbc3_1280.jpg https://www.pharmaceutical-business-review.com/news/kite-cell-therapy-facility-gets-fda-approval/ 2022-04-22T09:54:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/national-cancer-institute-QMmKpJ557iQ-unsplash.jpg https://www.pharmaceutical-business-review.com/news/tvardi-therapeutics-odd-tti-101-hcc/ 2022-04-25T11:09:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/medications-g22April2022.jpg https://www.pharmaceutical-business-review.com/news/benevolentai-dndi-ai-research-project-dengue/ 2022-04-25T11:09:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/mosquito-21April2022.jpg https://www.pharmaceutical-business-review.com/news/fda-astrazenecas-tremelimumab-hcc/ 2022-04-27T05:54:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/HCC.jpg https://www.pharmaceutical-business-review.com/news/roches-tecentriq-chmp-recommendation-early-nsclc/ 2022-04-27T05:55:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/Roche-drug-25April2022.png https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-astrazenecas-enhertu-btd-her2-low-metastatic-breast-cancer/ 2022-04-28T20:24:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/woman-27April2022.jpg https://www.pharmaceutical-business-review.com/news/us-fda-indication-supernus-qelbree-adhd/ 2022-05-02T09:36:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/Children.jpg https://www.pharmaceutical-business-review.com/news/ec-marketing-authorisation-kapruvia-pruritus-hemodialysis-patients/ 2022-05-02T13:27:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/hospital-29April2022.jpg https://www.pharmaceutical-business-review.com/news/pfizer-biohaven-vydura-marketing-authorisation-ec/ 2022-05-02T13:27:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/04/woman-28April2022.jpg https://www.pharmaceutical-business-review.com/news/intravac-licensing-deal-whooping-cough-vaccine/ 2022-05-03T01:00:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/coughing-3May2022.jpg https://www.pharmaceutical-business-review.com/news/sapience-orphan-designation-st101-advanced-melanoma/ 2022-05-04T09:45:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/Melanoma_Cells.jpg https://www.pharmaceutical-business-review.com/news/apnimed-funding-treatments-development-osa/ 2022-05-05T09:01:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/Sleeping.jpg https://www.pharmaceutical-business-review.com/news/novartis-ec-approval-jakavi-gvhd/ 2022-05-06T09:27:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/Novartis.jpg https://www.pharmaceutical-business-review.com/news/inxmed-funding-cancer-therapies/ 2022-05-09T09:02:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/Cancer.jpg https://www.pharmaceutical-business-review.com/news/gns-arvinas-neurodegenerative-drug/ 2022-05-10T08:51:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/Brain.jpg https://www.pharmaceutical-business-review.com/news/moma-therapeutics-funding-oncology/ 2022-05-11T09:14:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/Oncology.jpg https://www.pharmaceutical-business-review.com/news/artax-biopharma-small-molecule-agent/ 2022-05-16T09:43:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/Medicines.jpg https://www.pharmaceutical-business-review.com/news/statera-biopharma-lay-sciences-strategic-partnership/ 2022-05-17T10:03:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/stomach-16May2022.jpg https://www.pharmaceutical-business-review.com/news/stealth-fda-orphan-drug-designation-elamipretide/ 2022-05-17T10:03:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/Duchenne-muscular-dystrophy.jpg https://www.pharmaceutical-business-review.com/news/proteros-expands-oncology-collaboration-astrzeneca/ 2022-05-19T09:38:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/laboratory-17May2022.jpg https://www.pharmaceutical-business-review.com/news/swanbio-new-gene-therapies-neurological-conditions/ 2022-05-20T10:50:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/x-ray-19May2022.jpg https://www.pharmaceutical-business-review.com/news/procaps-to-buy-grupo-somar/ 2022-05-20T10:50:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/medications-1853400_1280.jpg https://www.pharmaceutical-business-review.com/news/inceptor-bio-raises-37m-car-t-lead-programme/ 2022-05-24T11:34:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/cells-20May2022.jpg https://www.pharmaceutical-business-review.com/news/novartis-cosentyx-chmp-positive-opinion-childhood-arthritic-conditions/ 2022-05-25T11:35:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/girl-23May2022.jpg https://www.pharmaceutical-business-review.com/news/castle-creek-biosciences-raises-112-8m-gene-therapies/ 2022-05-26T06:59:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/gene-26May2022.jpg https://www.pharmaceutical-business-review.com/news/ema-orphan-drug-designation-cornerstone-pharmaceuticals-cpi-613-devimistat/ 2022-05-26T07:00:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/1280px-bile-cancer_-25May2022.jpg https://www.pharmaceutical-business-review.com/news/fda-biohavens-nda-zavegepant-nasal-spray/ 2022-05-26T07:01:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/heache-24May2022.jpg https://www.pharmaceutical-business-review.com/news/novomedix-nih-grant-advance-nmx1-tnbc/ 2022-05-27T06:15:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/Breast-cancer-27May2022.jpg https://www.pharmaceutical-business-review.com/news/fda-priority-review-sanofi-regeneron-dupixent-sbla/ 2022-05-31T10:34:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/psoriasis-g0ec1ea5ec_1280.jpg https://www.pharmaceutical-business-review.com/news/us-fda-approves-amneals-biosimilar/ 2022-05-31T10:34:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/Neutropenia.jpg https://www.pharmaceutical-business-review.com/news/pharmenable-denali-partner-neurodegenerative-disease-drugs/ 2022-05-31T10:35:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/nerve-cells-gc79aebb93_1280.jpg https://www.pharmaceutical-business-review.com/news/fda-priotheras-aml-therapy/ 2022-05-31T14:15:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/05/Myeloblast_with_Auer_rod_smear_2010-01-27.jpg https://www.pharmaceutical-business-review.com/news/sapience-cancer-therapy-programmes/ 2022-06-01T11:35:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/cdc-_HvUN5xlv7I-unsplash.jpg https://www.pharmaceutical-business-review.com/news/fda-breakthrough-therapy-designation-haemophilia-a/ 2022-06-02T08:35:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/Sobi-sign-building_0.jpg https://www.pharmaceutical-business-review.com/news/vbi-vaccines-hepatitis-b-vaccine-mhra/ 2022-06-02T13:47:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/Ground_glass_hepatocytes_high_mag_cropped.jpg https://www.pharmaceutical-business-review.com/news/upstream-bio-treatments-inflammatory-diseases/ 2022-06-03T10:52:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/sincerely-media-jGkih_l3fV0-unsplash.jpg https://www.pharmaceutical-business-review.com/news/china-approves-cstone-sugemalimab/ 2022-06-06T09:58:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/carcinoma-6thJune.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-gsk-priorix/ 2022-06-07T10:04:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/GSK-7thJune.jpg https://www.pharmaceutical-business-review.com/news/fda-sanofi-regeneron-dupixent-atopic-dermatitis/ 2022-06-08T10:20:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/luke-michael-EOwsjoz6MCk-unsplash.jpg https://www.pharmaceutical-business-review.com/news/roche-eu-follicular-lymphoma-treatment/ 2022-06-09T07:43:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/1620px-Follicular_lymphoma_-_low_mag.jpg https://www.pharmaceutical-business-review.com/news/olema-aurigene-develop-therapies-cancer/ 2022-06-10T08:02:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/national-cancer-institute-Vb0GY3PWSSM-unsplash.jpg https://www.pharmaceutical-business-review.com/news/bavarian-nordics-smallpox-monkeypox-vaccine-doses/ 2022-06-13T09:45:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/mufid-majnun-cM1aU42FnRg-unsplash.jpg https://www.pharmaceutical-business-review.com/news/eli-lilly-incyte-fda-severe-alopecia-areata-medicine/ 2022-06-14T16:07:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/1440px-Eli_Lilly_Corporate_Center_Indianapolis_Indiana_USA.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-option-acquire-trutino-biosciences/ 2022-06-15T07:53:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/dna-15June2022.jpg https://www.pharmaceutical-business-review.com/news/immunogen-obt-antibody-drug-conjugates/ 2022-06-15T08:02:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/national-cancer-institute-Cx0LsYrM_Ns-unsplash.jpg https://www.pharmaceutical-business-review.com/news/quoin-pharmaceuticals-agreement-winhealth-pharma/ 2022-06-16T10:21:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/hands-16June2022.jpg https://www.pharmaceutical-business-review.com/news/fda-approves-abbvie-skyrizi-crohns-disease/ 2022-06-20T09:19:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/AbbVie-1-20thJune.jpg https://www.pharmaceutical-business-review.com/news/therorna-financing-round/ 2022-06-21T08:45:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/corona-21stJune.jpg https://www.pharmaceutical-business-review.com/news/abbvie-snda-fda-atogepant-label-expansion/ 2022-06-22T11:06:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/eyJ3IjoyMDQ4LCJoIjoyMDQ4LCJzY29wZSI6ImFwcCJ9.jpg https://www.pharmaceutical-business-review.com/news/vbi-orphan-drug-designation-glioblastoma-therapy/ 2022-06-22T14:17:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/1620px-Oligodendroglioma1_high_mag.jpg https://www.pharmaceutical-business-review.com/news/ec-rhythm-imcivree-renal-impairment/ 2022-06-23T10:39:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/pinch-g3312274bc_1280.jpg https://www.pharmaceutical-business-review.com/news/fda-ellipses-advanced-ret-altered-cancer/ 2022-06-23T13:59:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/national-cancer-institute-zoFbfT0M_BU-unsplash.jpg https://www.pharmaceutical-business-review.com/news/fda-novartis-tafinlar-mekinist/ 2022-06-24T10:23:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/novartis-campus-forum-1-banting-1-fabrikstrasse.jpg https://www.pharmaceutical-business-review.com/news/fda-review-emergent-anthrax-vaccine/ 2022-06-27T09:25:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/anthrax-27thJune.jpg https://www.pharmaceutical-business-review.com/news/ec-novartis-cosentyx-arthritis-children/ 2022-06-28T09:08:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/little-girl-gdd9893344_1280-1.jpg https://www.pharmaceutical-business-review.com/news/chmp-abbvie-axial-spondyloarthritis-therapy/ 2022-06-28T14:29:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/eyJ3IjoyMDQ4LCJoIjoyMDQ4LCJzY29wZSI6ImFwcCJ9-1.jpg https://www.pharmaceutical-business-review.com/news/sanofi-ec-pompe-disease-therapy/ 2022-06-29T09:43:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/1457px-Pompe_vacuoles.jpg https://www.pharmaceutical-business-review.com/news/palleon-henlius-bifunctional-sialidase-therapies/ 2022-06-29T14:04:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/laboratory-g40c244e27_1280.jpg https://www.pharmaceutical-business-review.com/news/janssen-fda-breakthrough-designation-myeloma/ 2022-06-30T10:02:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/06/1440px-Cast_nephropathy_-_2_cropped_-_very_high_mag.jpg https://www.pharmaceutical-business-review.com/news/generian-astellas-undruggable-therapeutic-targets/ 2022-06-30T13:54:04+00:00 https://www.pharmaceutical-business-review.com/news/mesh-multiomic-chronic-metabolic-disease-medicines/ 2022-07-01T09:46:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/62bd9bc588a3659732b3c9d5_Clinical-research-data-Medium.jpg https://www.pharmaceutical-business-review.com/news/regeneron-acquisition-sanofi-libtayo/ 2022-07-04T11:00:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/1440px-New_Eastview_office_bldg_jeh.jpg https://www.pharmaceutical-business-review.com/news/mogrify-astellas-sensorineural-hearing-loss/ 2022-07-05T10:44:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/mark-paton-bmzkW_nN0pQ-unsplash.jpg https://www.pharmaceutical-business-review.com/news/fda-priority-review-eisai-lecanemab/ 2022-07-06T11:14:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/Eisai_Head_Office.jpg https://www.pharmaceutical-business-review.com/news/turnstone-moffitt-cancer-center-til-cell-therapies/ 2022-07-07T09:46:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/immune-cells-attacking-cancer-cells-1440.jpg https://www.pharmaceutical-business-review.com/news/fda-anthos-cancer-associated-thrombosis-therapy/ 2022-07-11T10:33:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/4337750722_ec91a12d12_o.jpg https://www.pharmaceutical-business-review.com/news/wuxi-xdc-abtis-adc-products/ 2022-07-11T12:36:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/MK402565.jpg https://www.pharmaceutical-business-review.com/news/exelixis-ryvu-targeted-cancer-therapies/ 2022-07-11T16:36:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/national-cancer-institute-aelk4Tn0vlI-unsplash.jpg https://www.pharmaceutical-business-review.com/news/inspirna-advance-cancer-drugs-development/ 2022-07-12T10:29:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/buildings-chicago-city-36369-1.jpg https://www.pharmaceutical-business-review.com/news/sk-biopharmaceuticals-licensing-agreement-eurofarma-cenobamate/ 2022-07-15T06:19:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/epilepsy.jpg https://www.pharmaceutical-business-review.com/news/orion-biotechnology-canada-peptilogics-collaboration/ 2022-07-15T06:28:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/laboratory-13July2022.jpg https://www.pharmaceutical-business-review.com/news/neoimmunetech-orphan-drug-designation/ 2022-07-15T06:41:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/Histopathology_of_glioblastoma.jpg https://www.pharmaceutical-business-review.com/news/sk-biopharmaceuticals-eurofarma-epilepsy-therapy/ 2022-07-15T14:03:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/Pyramidal_hippocampal_neuron_40x.jpg https://www.pharmaceutical-business-review.com/news/bavarian-nordic-monkeypox-vaccine-doses-us/ 2022-07-18T11:23:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/injection-g91278aff2_1280.jpg https://www.pharmaceutical-business-review.com/news/camp4-therapeutics-100m-round-advance-regrna-programmes/ 2022-07-21T06:41:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/dna-21July2022.jpg https://www.pharmaceutical-business-review.com/news/avista-therapeutics-roche-aav-gene-therapy-vectors-eyes/ 2022-07-21T06:44:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/eye-20July2022.jpg https://www.pharmaceutical-business-review.com/news/sri-amylyx-identify-als-drug-candidates/ 2022-07-21T06:44:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/dr-david-andrews.jpg https://www.pharmaceutical-business-review.com/news/chmp-astrazenecas-tezspire-approval-treat-severe-asthma/ 2022-07-26T08:59:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/Child-26July2022.jpg https://www.pharmaceutical-business-review.com/news/qbiotics-ind-solid-tumours-therapy-trial/ 2022-07-26T09:44:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/injection-g3f6aff27a_1280.jpg https://www.pharmaceutical-business-review.com/news/bharat-biotechs-covaxin-safe-subjects-clinical-trials/ 2022-07-26T09:44:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/vaccine-22July2022.jpg https://www.pharmaceutical-business-review.com/news/precision-replicate-develop-srrna-therapies/ 2022-07-27T10:58:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/national-cancer-institute-LxPrHCm8-TI-unsplash.jpg https://www.pharmaceutical-business-review.com/news/bridgene-develop-imtac-platform-cancer-drugs/ 2022-07-28T10:27:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/national-cancer-institute-fOLO2hDMsa4-unsplash.jpg https://www.pharmaceutical-business-review.com/news/viiv-healthcare-medicines-patent-pool-hiv-drug/ 2022-07-29T10:53:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/07/national-cancer-institute-cI8T6zeDbZw-unsplash.jpg https://www.pharmaceutical-business-review.com/news/omeros-fda-orphan-drug-pnh-therapy/ 2022-08-01T11:45:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/Haemolytic_Anaemia.jpg https://www.pharmaceutical-business-review.com/news/fda-priority-review-gamida-cell-omidubicel/ 2022-08-02T09:06:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/national-cancer-institute-XknuBmnjbKg-unsplash.jpg https://www.pharmaceutical-business-review.com/news/transcode-md-anderson-advance-cancer-therapies/ 2022-08-03T11:03:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/1659364000057.jpg https://www.pharmaceutical-business-review.com/news/roche-genentech-license-deal-kiniksa-vixarelimab/ 2022-08-04T11:11:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/1587px-Genentech_Building_31.jpg https://www.pharmaceutical-business-review.com/news/acadia-pharmaceuticals-crl-snda-nuplazid-adp/ 2022-08-05T10:14:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/old-5August2022.jpg https://www.pharmaceutical-business-review.com/news/epigenic-advance-gene-editing-therapy/ 2022-08-08T10:19:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/sangharsh-lohakare-Iy7QyzOs1bo-unsplash.jpg https://www.pharmaceutical-business-review.com/news/bioduro-sundia-x-chem-del-technology-services/ 2022-08-09T09:33:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/microbiology-gf12c4ff9d_1280.jpg https://www.pharmaceutical-business-review.com/news/eli-lilly-citrate-free-taltz-formulation/ 2022-08-09T13:42:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/1440px-Eli_Lilly_Corporate_Center_Indianapolis_Indiana_USA.jpg https://www.pharmaceutical-business-review.com/news/fda-eua-bavarian-nordic-jynneos-monkeypox/ 2022-08-10T10:35:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/bn_manufacturing1_300dpi.jpg https://www.pharmaceutical-business-review.com/news/taiwan-fda-everest-xerava-intra-abdominal/ 2022-08-11T12:19:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/stomach-pain-gb85ee235b_1280.jpg https://www.pharmaceutical-business-review.com/news/fda-genentechs-snda-influenza-therapy/ 2022-08-12T12:37:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/mladen-borisov-RzbUUaP2JXY-unsplash.jpg https://www.pharmaceutical-business-review.com/news/china-innocare-orelabrutinib-lymphoma/ 2022-08-15T03:56:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/1620px-Marginal_zone_lymphoma_-_kidney_-_high_mag.jpg https://www.pharmaceutical-business-review.com/news/inhibrx-orphan-drug-designation-chondrosarcoma/ 2022-08-16T10:34:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/23197709849_9de9857046_o.jpg https://www.pharmaceutical-business-review.com/news/senda-medicines-platform-development/ 2022-08-17T10:48:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/national-cancer-institute-QMmKpJ557iQ-unsplash.jpg https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-turning-point/ 2022-08-18T10:27:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/02-LVL-Exterior-Sign-101520-media.jpg https://www.pharmaceutical-business-review.com/news/oncopeptides-eu-marketing-rrmm-therapy/ 2022-08-19T10:41:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/1440px-Cast_nephropathy_-_2_cropped_-_very_high_mag.jpg https://www.pharmaceutical-business-review.com/news/fda-axsome-therapeutics-auvelity/ 2022-08-22T11:00:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/Depression.jpg https://www.pharmaceutical-business-review.com/news/indonesia-takeda-dengue-qdenga/ 2022-08-23T10:04:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/dengue-gd52a76c93_1280.png https://www.pharmaceutical-business-review.com/news/bavarian-nordic-paho-monkeypox-vaccines/ 2022-08-25T09:29:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/52100927731_246c86698a_k.jpg https://www.pharmaceutical-business-review.com/news/ec-novartis-scemblix-chronic-myeloid-leukemia/ 2022-08-30T09:39:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/facing-banting-1-novartis-campus-basel.jpg https://www.pharmaceutical-business-review.com/news/merck-end-stage-renal-disease-therapy-fda/ 2022-08-30T10:51:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/robina-weermeijer-sRXCFkJahGk-unsplash.jpg https://www.pharmaceutical-business-review.com/news/novavax-mhra-marketing-nuvaxovid/ 2022-08-30T14:17:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/2022-0222-EU-UK-Vial.jpg https://www.pharmaceutical-business-review.com/news/japan-astrazeneca-ultomiris-generalised-myasthenia-gravis/ 2022-08-30T14:18:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/cq5dam.web_.1200.AstraZeneca-Cambridge-Biomedical-Campus.jpg https://www.pharmaceutical-business-review.com/news/okyo-pharma-ind-fda-dry-eye-disease/ 2022-08-31T02:32:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/08/amanda-dalbjorn-UbJMy92p8wk-unsplash.jpg https://www.pharmaceutical-business-review.com/news/amneal-nda-fda-parkinsons-disease-treatment/ 2022-09-01T11:12:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/pill-g145475d12_1280.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-fda-gpp-flares/ 2022-09-02T10:41:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/Image-for-FDA-Press-release_1440x810px.jpg https://www.pharmaceutical-business-review.com/news/carsgen-car-t-cells-batch/ 2022-09-05T10:42:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/273d50bb08d5f15224100a8677779c5-1.jpg https://www.pharmaceutical-business-review.com/news/pfizer-gbs6-fda-breakthrough-therapy/ 2022-09-08T10:30:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/juan-encalada-SCteCA0Mf1A-unsplash.jpg https://www.pharmaceutical-business-review.com/news/evaxion-umass-chan-nih-gonorrhea-vaccine/ 2022-09-08T16:57:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/1764px-Gram-stain_of_gonorrhoea.jpg https://www.pharmaceutical-business-review.com/news/china-astrazeneca-forxiga-chronic-kidney-disease/ 2022-09-08T16:57:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/original.jpg https://www.pharmaceutical-business-review.com/news/fda-revance-daxxify-injection-frown-lines/ 2022-09-09T08:04:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/Untitled.jpg https://www.pharmaceutical-business-review.com/news/celregen-license-cellusion-bullous-keratopathy/ 2022-09-12T10:34:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/woman-g521b01719_1280.jpg https://www.pharmaceutical-business-review.com/news/anheart-orphan-drug-nsclc/ 2022-09-13T10:46:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/1620px-Non-small_cell_lung_carcinoma_-_intermed_mag.jpg https://www.pharmaceutical-business-review.com/news/novome-advance-microbes-pipeline/ 2022-09-14T10:40:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/national-cancer-institute-Vb0GY3PWSSM-unsplash.jpg https://www.pharmaceutical-business-review.com/news/coave-imn-gene-neurodegenerative-disorders/ 2022-09-15T08:36:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/national-cancer-institute-GcrSgHDrniY-unsplash.jpg https://www.pharmaceutical-business-review.com/news/fda-mallinckrodt-hepatorenal-syndrome/ 2022-09-15T14:41:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/1620px-Cirrhosis_high_mag.jpg https://www.pharmaceutical-business-review.com/news/neurobo-dong-a-two-drug-candidates/ 2022-09-16T09:11:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/1620px-Lobular_necro-inflammation_-_high_mag.jpg https://www.pharmaceutical-business-review.com/news/kite-yescarta-large-b-cell-lymphoma/ 2022-09-19T14:24:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/1601px-Diffuse_large_B_cell_lymphoma_-_cytology_low_mag.jpg https://www.pharmaceutical-business-review.com/news/fda-seagen-colorectal-cancer-medicine/ 2022-09-20T09:33:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/Micrograph_of_colorectal_carcinoma_with_dirty_necrosis.jpg https://www.pharmaceutical-business-review.com/news/netris-orano-clb-radio-conjugates/ 2022-09-21T07:02:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/national-cancer-institute-Cx0LsYrM_Ns-unsplash.jpg https://www.pharmaceutical-business-review.com/news/alnylam-eu-hattr-amyloidosis-therapy/ 2022-09-21T13:32:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/Amyloidosis_blood_vessels_HE.jpg https://www.pharmaceutical-business-review.com/news/lilly-retevmo-fda-solid-tumours/ 2022-09-22T10:40:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/pill-gac7c65550_1280.jpg https://www.pharmaceutical-business-review.com/news/china-astrazeneca-merck-lynparza-ovarian-cancer/ 2022-09-27T10:15:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/original-1.jpg https://www.pharmaceutical-business-review.com/news/sciwind-synerk-therapeutics-liver-metabolic-diseases/ 2022-09-28T11:18:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/Synerk.jpg https://www.pharmaceutical-business-review.com/news/nice-pembrolizumab-treat-melanoma/ 2022-09-28T11:18:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/Metastatic_Melanoma_Cells.jpg https://www.pharmaceutical-business-review.com/news/arsenalbio-genentech-partner-t-cell-therapies-cancer/ 2022-09-28T11:36:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/Cancer-trail-Genetech.jpg https://www.pharmaceutical-business-review.com/news/fda-sanofi-regeneron-dupixent-prurigo-nodularis/ 2022-09-29T11:11:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/psoriasis-ga5de8f552_1280.jpg https://www.pharmaceutical-business-review.com/news/vanda-olipass-aso-therapeutics/ 2022-09-30T10:38:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/09/vanda_pharmaceuticals_olipass.jpg https://www.pharmaceutical-business-review.com/news/personalis-research-collaboration-duke-university-olink-proteomics/ 2022-10-05T06:40:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/Study-05Oct2022.jpg https://www.pharmaceutical-business-review.com/news/alexion-astrazeneca-logicbio-therapeutics/ 2022-10-05T06:43:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/original.jpg https://www.pharmaceutical-business-review.com/news/aerorx-hcmed-nebulised-combination-copd/ 2022-10-05T06:43:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/syringedrug.jpg https://www.pharmaceutical-business-review.com/news/eiger-eua-fda-covid-19-treatment/ 2022-10-06T10:49:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/virus-g4c14dd677_1280.jpg https://www.pharmaceutical-business-review.com/news/fda-label-expansion-alnylams-oxlumo/ 2022-10-07T12:04:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/marisa-howenstine-Cq9slNxV8YU-unsplash.jpg https://www.pharmaceutical-business-review.com/news/china-innovent-hepatocellular-carcinoma/ 2022-10-10T12:21:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/1440px-Hepatocellular_carcinoma_intermed_mag.jpg https://www.pharmaceutical-business-review.com/news/chinas-jw-therapeutic-follicular-lymphoma-therapy/ 2022-10-11T13:02:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/1620px-Follicular_lymphoma_-_low_mag.jpg https://www.pharmaceutical-business-review.com/news/eligo-eb003-fda-orphan-drug-designation/ 2022-10-12T11:09:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/Schizocyte_smear_2009-12-22.jpg https://www.pharmaceutical-business-review.com/news/sisaf-orphan-drug-sis-101-ado/ 2022-10-13T11:44:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/Bone-image-2-825x510-1.jpg https://www.pharmaceutical-business-review.com/news/adalta-gpcr-cancer-treatment-approach/ 2022-10-14T11:47:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/lucas-vasques-9vnACvX2748-unsplash.jpg https://www.pharmaceutical-business-review.com/news/ema-chmp-novartis-prostate-cancer/ 2022-10-17T11:22:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/novartis-pavillon-novartis-campus-banting-1-background.jpg https://www.pharmaceutical-business-review.com/news/bavarian-nordic-smallpox-monkeypox-vaccine/ 2022-10-17T14:04:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/52097193159_6be76f8d61_k.jpg https://www.pharmaceutical-business-review.com/news/kite-ec-approval-yescarta-dlbcl-hgbl/ 2022-10-18T10:49:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/Cancer.jpg https://www.pharmaceutical-business-review.com/news/kite-refuge-license-gene-expression-platform-blood-cancers/ 2022-10-21T10:32:41+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/blood-21Oct2022.jpg https://www.pharmaceutical-business-review.com/news/jazz-zymeworks-antibody-development/ 2022-10-21T10:33:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/lucas-vasques-9vnACvX2748-unsplash-1.jpg https://www.pharmaceutical-business-review.com/news/charles-river-nanoscope-gene-therapies/ 2022-10-21T10:34:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/sangharsh-lohakare-Iy7QyzOs1bo-unsplash.jpg https://www.pharmaceutical-business-review.com/news/ars-pharma-nda-neffy-allergic-reactions-type-i/ 2022-10-24T06:17:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/Skin-24Oct2022.jpg https://www.pharmaceutical-business-review.com/news/fda-daiichi-sankyo-aml-medicine/ 2022-10-25T10:28:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/Auer_rods.jpg https://www.pharmaceutical-business-review.com/news/normunity-immuno-oncology-therapies/ 2022-10-26T09:54:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/lab-g4ba7f7ac7_1280.jpg https://www.pharmaceutical-business-review.com/news/ema-almiralls-atopic-dermatitis-therapy/ 2022-10-31T17:22:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/Almirall.jpg https://www.pharmaceutical-business-review.com/news/ariceum-ambiopharm-peptide-conjugates/ 2022-10-31T17:23:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/national-cancer-institute-aelk4Tn0vlI-unsplash.jpg https://www.pharmaceutical-business-review.com/news/csl-translational-sciences-thrombus-dissolving-drug/ 2022-10-31T17:23:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/10/milad-fakurian-58Z17lnVS4U-unsplash.jpg https://www.pharmaceutical-business-review.com/news/epivax-intravacc-cepi-betacoronavirus/ 2022-11-01T10:26:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/national-cancer-institute-fOLO2hDMsa4-unsplash.jpg https://www.pharmaceutical-business-review.com/news/pharmather-cwru-rett-syndrome-therapy/ 2022-11-02T08:26:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/2270px-Rett_girl_with_stereotyped_hands_movements.jpg https://www.pharmaceutical-business-review.com/news/beigene-ec-mzl-therapy/ 2022-11-03T09:18:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/1620px-Marginal_zone_lymphoma_-_kidney_-_high_mag.jpg https://www.pharmaceutical-business-review.com/news/reithera-new-production-facility/ 2022-11-04T09:28:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/2000l-bioreactor-768x731-1.jpg https://www.pharmaceutical-business-review.com/news/amgen-olpasiran-cardiovascular-disease/ 2022-11-09T09:02:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/robina-weermeijer-qIK_fc-4fmw-unsplash.jpg https://www.pharmaceutical-business-review.com/news/mhra-approves-beyfortus-nirsevimab-rsv-infants/ 2022-11-10T09:04:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/baby-10Nov2022.jpg https://www.pharmaceutical-business-review.com/news/immunomic-therapeutics-ftd-iti-3000-programme-merkel-cell-carcinoma/ 2022-11-10T09:05:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/Merkelcellcarcinoma_9Nov2022.jpg https://www.pharmaceutical-business-review.com/news/navrogen-us-nci-nav-001/ 2022-11-10T09:05:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/national-cancer-institute-aelk4Tn0vlI-unsplash.jpg https://www.pharmaceutical-business-review.com/news/harbour-biomed-moderna-immunotherapies/ 2022-11-11T10:35:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/science-gb93785c76_1280.jpg https://www.pharmaceutical-business-review.com/news/fda-amneal-parkinsons-disease/ 2022-11-16T06:01:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/Lewy_Body_alphaSynuclein.jpg https://www.pharmaceutical-business-review.com/news/nice-msd-pembrolizumab-breast-cancer/ 2022-11-17T08:51:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/cell-breast-cancer_2017-3.jpg https://www.pharmaceutical-business-review.com/news/marinus-pharmaceuticals-collaboration-agreement-tenacia-biotechnology/ 2022-11-18T05:37:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/medications-18Nov2022.jpg https://www.pharmaceutical-business-review.com/news/curevo-vaccine-26m-series-a1-round/ 2022-11-18T05:38:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/syringe-17Nov2022.jpg https://www.pharmaceutical-business-review.com/news/cg-oncology-120m-series-e-round/ 2022-11-18T05:38:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/treatment-16Nov2022.jpg https://www.pharmaceutical-business-review.com/news/kempharm-orphan-drug-designation-prodrug/ 2022-11-21T09:00:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/Sleep-disorder.jpg https://www.pharmaceutical-business-review.com/news/graybug-calcimedica-biopharmaceutical-company/ 2022-11-22T09:09:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/Drugs.jpg https://www.pharmaceutical-business-review.com/news/innocare-approval-singapore-mantle-cell-lymphoma/ 2022-11-23T08:25:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/Mantle_Cell_Lymphoma.jpg https://www.pharmaceutical-business-review.com/news/fda-takedas-dengue-vaccine/ 2022-11-24T10:33:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/dengue-gd5f53229f_1280.png https://www.pharmaceutical-business-review.com/news/junshi-marketing-authorisation-toripalimab/ 2022-11-25T07:39:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/1620px-Nasopharyngeal_carcinoma_-_EBER_-_very_low_mag.jpg https://www.pharmaceutical-business-review.com/news/everest-taiwan-korea-nefecon/ 2022-11-28T11:21:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/yvette-s-AIxYrWL0Rqg-unsplash.jpg https://www.pharmaceutical-business-review.com/news/fda-kintara-breast-cancer/ 2022-11-29T10:53:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/Breast_carcinoma_in_a_lymph_node.jpg https://www.pharmaceutical-business-review.com/news/aldeyra-dry-eye-disease/ 2022-11-30T11:18:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/11/amanda-dalbjorn-UbJMy92p8wk-unsplash.jpg https://www.pharmaceutical-business-review.com/news/iecure-advance-gene-editing/ 2022-12-01T10:57:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/aditya-romansa-5zp0jym2w9M-unsplash.jpg https://www.pharmaceutical-business-review.com/news/rallybio-abcellera-rare-diseases/ 2022-12-02T08:40:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/national-cancer-institute-82BHTkmkDfU-unsplash.jpg https://www.pharmaceutical-business-review.com/news/fda-ideaya-uveal-melanoma-therapy/ 2022-12-07T07:18:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/filipp-romanovski-w7SbnVlCQKg-unsplash.jpg https://www.pharmaceutical-business-review.com/news/ema-gsk-application-myelofibrosis/ 2022-12-07T07:19:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/new-gskh_thumb.jpg https://www.pharmaceutical-business-review.com/news/caris-hummingbird-bioscience-collaborate-tanti-her3-therapy/ 2022-12-07T07:20:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/laboratory-07Dec2022.jpg https://www.pharmaceutical-business-review.com/news/moleculin-fast-track-designation-glioblastoma-multiforme/ 2022-12-08T10:18:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/Histopathology_of_glioblastoma.jpg https://www.pharmaceutical-business-review.com/news/health-canada-vbi-vaccine-prehevbrio/ 2022-12-09T10:39:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/Ground_glass_hepatocytes_high_mag_cropped.jpg https://www.pharmaceutical-business-review.com/news/hitgen-nitrase-drug-discovery/ 2022-12-12T11:22:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/national-cancer-institute-82BHTkmkDfU-unsplash-1.jpg https://www.pharmaceutical-business-review.com/news/merck-buy-imago-biosciences/ 2022-12-13T11:30:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/KW.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-marketing-spesolimab/ 2022-12-14T11:34:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/Micrograph_of_psoriasis_vulgaris.jpg https://www.pharmaceutical-business-review.com/news/innovent-lg-chem-gout-disease-therapy/ 2022-12-15T09:28:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/Trials.jpg https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-and-astrazenecas-enhertu-approval-eu/ 2022-12-20T11:52:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/stomach-pain-20Dec2022.jpg https://www.pharmaceutical-business-review.com/news/alchemab-mdc-huntingtons-disease/ 2022-12-20T11:53:36+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/Neuron_with_mHtt_inclusion.jpg https://www.pharmaceutical-business-review.com/news/gilgamesh-treatments-mental-health/ 2022-12-20T11:53:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/gadiel-lazcano-ulPAVuxITEw-unsplash.jpg https://www.pharmaceutical-business-review.com/news/kite-agreement-acquire-tmunity-therapeutics/ 2022-12-21T09:14:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/Lab-research.jpg https://www.pharmaceutical-business-review.com/news/vistagen-to-acquire-pherin/ 2022-12-22T07:09:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/robina-weermeijer-IHfOpAzzjHM-unsplash-5-e1671692627815.jpg https://www.pharmaceutical-business-review.com/news/genmab-lymphoma-treatment-japan/ 2022-12-23T06:07:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/julia-koblitz-RlOAwXt2fEA-unsplash-7-e1671775328969.jpg https://www.pharmaceutical-business-review.com/news/japan-mediwound-burn-nexobrid/ 2022-12-26T12:28:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/alexey-demidov-Ea9npW5Q_GA-unsplash.jpg https://www.pharmaceutical-business-review.com/news/hikma-licensing-junshi-toripalimab/ 2022-12-27T10:33:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/mufid-majnun-1PkQljcl3T0-unsplash.jpg https://www.pharmaceutical-business-review.com/news/fda-acer-olpruva-urea-cycle-disorders/ 2022-12-28T11:37:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/michal-parzuchowski-7TWRwDjfGew-unsplash.jpg https://www.pharmaceutical-business-review.com/news/fda-pfizer-meningococcal-vaccine/ 2023-01-03T12:11:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2022/12/1592px-Pfizer_World_Headquarters_Entrance.jpg https://www.pharmaceutical-business-review.com/news/china-beigene-hepatocellular-carcinoma/ 2023-01-04T11:32:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/5433130015_d041079157_k.jpg https://www.pharmaceutical-business-review.com/news/chinas-nmpa-accepts-legend-biotechs-nda-for-cilta-cel/ 2023-01-05T11:38:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/cancer-cell.jpg https://www.pharmaceutical-business-review.com/news/janssen-maa-european-medicines-agency-talquetamab/ 2023-01-06T09:07:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/1280px-Multiple_Myeloma.jpg https://www.pharmaceutical-business-review.com/news/spruce-biosciences-kaken-pharmaceutical-tildacerfont-cah/ 2023-01-09T11:32:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/medications-06Jan2023.jpg https://www.pharmaceutical-business-review.com/news/innovent-btd-china-nsclc-krasg12c-mutation-therapy/ 2023-01-09T11:32:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/Squamous_carcinoma_lung_cytology-05Jan2023.gif https://www.pharmaceutical-business-review.com/news/usfda-roches-bla-glofitamab-r-r-lbcl/ 2023-01-11T11:51:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/Mantle_cell_lymphoma_-_intermed_mag.jpg https://www.pharmaceutical-business-review.com/news/myrtelle-raaven-therapeutics-novel-gene-therapy-vectors/ 2023-01-12T10:02:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/Brain-12Jan2023.jpg https://www.pharmaceutical-business-review.com/news/recode-therapeutics-strategic-investment-cystic-fibrosis-foundation/ 2023-01-12T10:04:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/CF-11Jan2023.jpg https://www.pharmaceutical-business-review.com/news/us-fda-santhera-reveragens-vamorolone/ 2023-01-12T10:04:15+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/Duchenne-muscular-dystrophy.jpg https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-marketing-approval-covid-19-vaccine-japan/ 2023-01-13T10:41:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/coronavirus-13Jan2023.jpg https://www.pharmaceutical-business-review.com/news/eisai-marketing-authorization-application-ad/ 2023-01-16T11:03:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/AD.jpg https://www.pharmaceutical-business-review.com/news/bio-thera-solutions-bat1806-china-nmpa/ 2023-01-17T08:31:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/towfiqu-barbhuiya-3AsiVDsZnHg-unsplash.jpg https://www.pharmaceutical-business-review.com/news/us-fda-fast-track-designation-evaxion-biotechs-personalised-cancer-therapy/ 2023-01-20T04:08:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/PBR-20Jan2023.jpg https://www.pharmaceutical-business-review.com/news/forge-biologics-prime-designation-krabbe-drug/ 2023-01-20T04:15:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/Globoid_cell_leukodystrophy.jpg https://www.pharmaceutical-business-review.com/news/exegenesis-bio-fda-clearance-exg102-031/ 2023-01-20T04:15:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/Eye.jpg https://www.pharmaceutical-business-review.com/news/genexine-dna-vaccine-cervical-cancer/ 2023-01-23T09:49:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/Ca_in_situ_cervix_2.jpg https://www.pharmaceutical-business-review.com/news/rewind-therapeutics-raises-funding-clinical-development/ 2023-01-26T05:37:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/nerve-cells-26Jan2023.jpg https://www.pharmaceutical-business-review.com/news/aft-salus-pain-treatment-maxigesic-iv/ 2023-01-26T05:38:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/Medicines.jpg https://www.pharmaceutical-business-review.com/news/tscan-therapeutics-fda-clearance-ind/ 2023-01-26T05:38:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/Tumour.jpg https://www.pharmaceutical-business-review.com/news/ema-eisai-biogens-lecanemab/ 2023-01-27T09:25:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/Alzheimers.jpg https://www.pharmaceutical-business-review.com/news/us-fda-grants-fast-track-designation-artivas-ab-101/ 2023-02-01T04:53:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/02/PBR1-1Feb2023.png https://www.pharmaceutical-business-review.com/news/nanoscopes-stargardt-disease-fast-track/ 2023-02-01T04:58:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/Vision.jpg https://www.pharmaceutical-business-review.com/news/chmp-bristol-myers-squibbs-reblozyl/ 2023-02-01T04:58:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/01/B-Thal.jpg https://www.pharmaceutical-business-review.com/news/gsk-benlysta-systemic-sclerosis/ 2023-02-02T09:40:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/02/GSK.jpg https://www.pharmaceutical-business-review.com/news/purple-biotech-agreement-acquire-immunorizon/ 2023-02-03T09:33:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/02/national-cancer-institute-NbZQYileaOI-unsplash.jpg https://www.pharmaceutical-business-review.com/news/rmat-designation-rocket-pharmaceuticals-danon-disease/ 2023-02-08T11:00:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/02/man-08Feb2023.jpg https://www.pharmaceutical-business-review.com/news/fda-nda-filing-biogen-sage-zuranolone/ 2023-02-08T11:01:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/02/Depression.jpg https://www.pharmaceutical-business-review.com/news/us-fda-sbla-expanded-use-takedas-takhzyro/ 2023-02-08T11:02:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/02/Children-06Feb2023.jpg https://www.pharmaceutical-business-review.com/news/leo-pharma-atopic-dermatitis/ 2023-02-09T11:46:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/02/priscilla-du-preez-9e4n5-xvvbg-unsplash-1.jpg https://www.pharmaceutical-business-review.com/news/ema-accepts-alvotechs-avt04/ 2023-02-10T08:43:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/02/syringe-g530db8745_1920-1.jpg https://www.pharmaceutical-business-review.com/news/gsk-approval-fda-jemperli/ 2023-02-13T12:48:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/02/Endometrial_adenocarcinoma.jpg https://www.pharmaceutical-business-review.com/news/astex-mdi-neurodegenerative-drugs/ 2023-02-14T09:16:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/02/Brain.jpg https://www.pharmaceutical-business-review.com/news/ryne-biotechnology-cirm-grant-rndp-001/ 2023-02-15T09:15:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/02/Brain_PD.jpg https://www.pharmaceutical-business-review.com/news/fda-accepts-valnevas-chikungunya-vaccine-bla/ 2023-02-21T05:59:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/02/Chikungunya-21Feb2022.jpeg https://www.pharmaceutical-business-review.com/news/travere-therapeutics-fda-approval-filspari/ 2023-02-21T06:57:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/02/Kidney-model.jpg https://www.pharmaceutical-business-review.com/news/fresenius-kabis-biosimilar-cancer/ 2023-02-21T06:57:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/02/Syringe_and_Package.jpg https://www.pharmaceutical-business-review.com/news/coya-arscience-agreement-coya-301/ 2023-02-21T06:57:44+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/02/Neuro.jpg https://www.pharmaceutical-business-review.com/news/icosavax-fast-track-ivx-a12/ 2023-02-22T11:36:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/02/Human_Respiratory_Syncytial_Virus.jpg https://www.pharmaceutical-business-review.com/news/ema-sage-718-huntingtons-disease/ 2023-02-23T09:12:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/02/nerve-cells-g5058045cf_1280-2.jpg https://www.pharmaceutical-business-review.com/news/xspray-pharma-eversana-launch-cancer-therapy/ 2023-02-24T09:00:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/02/Hypolobated_small_megakaryocyte.jpg https://www.pharmaceutical-business-review.com/news/nexus-pharmaceuticals-fda-approval-emerphed-pre-filled-syringe/ 2023-03-02T11:33:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/EMERPHED-2March2023.png https://www.pharmaceutical-business-review.com/news/tempus-pfizer-cancer-drug/ 2023-03-02T11:35:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/national-cancer-institute-JxoWb7wHqnA-unsplash.jpg https://www.pharmaceutical-business-review.com/news/timbers-tmb-001-ec-xlri/ 2023-03-02T11:35:28+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/02/IchthyosisXlinked.jpg https://www.pharmaceutical-business-review.com/news/abbvie-chmp-upadacitinib-crohns/ 2023-03-02T11:36:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/02/stomach-pain-gb983b4e12_1280.jpg https://www.pharmaceutical-business-review.com/news/avenue-agreement-annji-pharmaceutical-aj201/ 2023-03-07T06:11:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/Laboratory.jpg https://www.pharmaceutical-business-review.com/news/selagine-grifols-develop-immunoglobulin-eye-drops/ 2023-03-08T09:14:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/Selagine_Antibody_based_eye_drop.jpg https://www.pharmaceutical-business-review.com/news/ractigen-orphan-drug-designation-als/ 2023-03-08T09:15:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/Therapy.jpg https://www.pharmaceutical-business-review.com/news/volastra-in-licenses-amgens-sovilnesib/ 2023-03-10T12:21:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/Cancer.jpg https://www.pharmaceutical-business-review.com/news/invox-pharma-f-star-therapeutics/ 2023-03-13T10:42:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/vitamins-g4f0b8d099_1280.jpg https://www.pharmaceutical-business-review.com/news/quell-series-b-neurodegenerative/ 2023-03-14T11:33:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/laboratory-g0d7227197_1920.jpg https://www.pharmaceutical-business-review.com/news/sumitovant-biopharma-acquisition-myovant-sciences/ 2023-03-15T06:50:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/Drugs-13March2023.jpg https://www.pharmaceutical-business-review.com/news/evergreen-theragnostics-15m-series-b-round/ 2023-03-16T06:42:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/PBR-14March2023.jpg https://www.pharmaceutical-business-review.com/news/chinas-nmpa-gsks-drug-application-review-nucala-sea/ 2023-03-17T10:39:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/asthma-15March2023.jpg https://www.pharmaceutical-business-review.com/news/mediar-therapeutics-financing-fibrosis-therapies/ 2023-03-20T09:36:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/PBR-16March2023.jpg https://www.pharmaceutical-business-review.com/news/everest-approval-xerava-ciai/ 2023-03-21T06:36:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/Xereva.jpg https://www.pharmaceutical-business-review.com/news/orion-approval-chinese-nmpa-darolutamide/ 2023-03-22T04:48:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/Prostatic_adenocarcinoma.jpg https://www.pharmaceutical-business-review.com/news/fda-fast-track-designation-arrowhead-pharmaceuticals-aro-apoc3/ 2023-03-23T11:39:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/PBR-21March2023.jpg https://www.pharmaceutical-business-review.com/news/dewpoint-novo-nordisk-drug-diabetic-complications/ 2023-03-24T12:57:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/Dew-Therapeutics.jpg https://www.pharmaceutical-business-review.com/news/fda-fast-track-prestiges-pbp1510/ 2023-03-24T12:58:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/cancercell.jpg https://www.pharmaceutical-business-review.com/news/macomics-collaboration-ono-pharmaceutical/ 2023-03-28T09:24:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/national-cancer-institute-lTlB51-XGP4-unsplash.jpg https://www.pharmaceutical-business-review.com/news/iovance-biotherapeutics-fda-melanoma/ 2023-03-29T09:34:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/melanoma.jpg https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-enhertu-japan/ 2023-03-30T09:19:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/Daichi.jpg https://www.pharmaceutical-business-review.com/news/navamedic-cash-offer-sensidose-acquisition/ 2023-03-31T10:20:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/swedish-drug.jpg https://www.pharmaceutical-business-review.com/news/oncovent-agreement-orient-europharma-oregovomab/ 2023-03-31T10:21:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/drug-taiwan.jpg https://www.pharmaceutical-business-review.com/news/talem-xyphos-cancer-therapeutic-candidates/ 2023-03-31T10:21:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/03/cancer-drug.jpg https://www.pharmaceutical-business-review.com/news/mosaic-therapeutics-oncology-therapies/ 2023-04-05T10:38:31+00:00 https://www.pharmaceutical-business-review.com/news/fda-orphan-drug-designation-huidagene-gene-therapy-blindness/ 2023-04-05T10:38:51+00:00 https://www.pharmaceutical-business-review.com/news/novartis-chmp-opinion-entresto-paediatric-heart-failure/ 2023-04-05T10:39:02+00:00 https://www.pharmaceutical-business-review.com/news/acelrx-pharmaceuticals-divestment-dsuvia-alora-pharmaceuticals/ 2023-04-11T11:41:43+00:00 https://www.pharmaceutical-business-review.com/news/tubitak-mam-drugs-pilot-scale-turkiye/ 2023-04-12T11:17:17+00:00 https://www.pharmaceutical-business-review.com/news/asieris-pharmaceuticals-subsidiary-drug-distribution-license/ 2023-04-13T10:13:50+00:00 https://www.pharmaceutical-business-review.com/news/immunebridge-new-cell-immunotherapies/ 2023-04-14T10:15:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/04/national-cancer-institute-XknuBmnjbKg-unsplash.jpg https://www.pharmaceutical-business-review.com/news/chiesi-farmaceutici-acquires-amryt-pharma/ 2023-04-17T11:51:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/04/medicines.jpg https://www.pharmaceutical-business-review.com/news/caris-flare-oncology-pipeline-advancement/ 2023-04-18T12:09:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/04/national-cancer-institute.jpg https://www.pharmaceutical-business-review.com/news/ablivas-nv354-receives-odd-us-fda/ 2023-04-19T11:27:05+00:00 https://www.pharmaceutical-business-review.com/news/fda-approval-cell-therapy-omisirge-blood-cancer/ 2023-04-20T11:48:57+00:00 https://www.pharmaceutical-business-review.com/news/ardelyx-nda-xphozah-fda/ 2023-04-21T12:01:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/04/lab-gbb3a4ddef_1280.jpg https://www.pharmaceutical-business-review.com/news/fda-ajinomoto-bio-pharma-fill-line/ 2023-04-24T11:21:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/04/Ajinomoto-Bio-Pharma.jpg https://www.pharmaceutical-business-review.com/news/bullfrog-ai-sage-oncology-assets/ 2023-04-25T11:18:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/04/1620px-Glioblastoma_-_very_high_mag.jpg https://www.pharmaceutical-business-review.com/news/novabay-introduce-cream-psoriasis/ 2023-04-26T11:24:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/04/CJ_cream_8oz_Pic.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-biotechnology-centre/ 2023-04-27T12:21:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/04/Boehringer-Ingelheim.jpg https://www.pharmaceutical-business-review.com/news/stablix-vertex-protein-stabilisation/ 2023-04-27T12:21:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/04/lucas-vasques-9vnACvX2748-unsplash.jpg https://www.pharmaceutical-business-review.com/news/amicus-chmp-opfolda-pompe-disease/ 2023-05-01T12:12:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/04/Pompe_vacuoles.jpg https://www.pharmaceutical-business-review.com/news/hansa-biopharma-collaboration-genethon/ 2023-05-02T08:47:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/04/national-cancer-institute-JxoWb7wHqnA-unsplash.jpg https://www.pharmaceutical-business-review.com/news/health-canada-arcutis-zoryve/ 2023-05-03T09:04:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/download.jpg https://www.pharmaceutical-business-review.com/news/fda-ascendis-transcon-pth/ 2023-05-04T10:35:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/1620px-Parathyroid_gland_intermed_mag.jpg https://www.pharmaceutical-business-review.com/news/tenaya-therapeutics-fast-track-designation-tn-201/ 2023-05-05T13:25:23+00:00 https://www.pharmaceutical-business-review.com/news/tetra-pharm-debuts-first-drug-germany/ 2023-05-08T10:30:18+00:00 https://www.pharmaceutical-business-review.com/news/neogap-cellerys-multiple-sclerosis/ 2023-05-09T09:13:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/83da05770e4b9792_800x800ar.png https://www.pharmaceutical-business-review.com/news/fda-nexus-manufacturing-facility/ 2023-05-10T11:07:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/Nexus_2021_WI_Photo_016.jpg https://www.pharmaceutical-business-review.com/news/life-bio-forge-gene-therapies/ 2023-05-11T09:43:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/national-cancer-institute-eHBGiF1MX74-unsplash.jpg https://www.pharmaceutical-business-review.com/news/sandoz-just-evotec-biologics-biosimilars/ 2023-05-12T10:15:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/louis-reed-pwcKF7L4-no-unsplash.jpg https://www.pharmaceutical-business-review.com/news/sgs-60-stake-nutrasource/ 2023-05-16T11:23:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/national-cancer-institute-oCLuFi9GYNA-unsplash.jpg https://www.pharmaceutical-business-review.com/news/chiesi-protalixs-prx-102-fda/ 2023-05-17T10:58:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/PBB_Protein_GLA_image.jpg https://www.pharmaceutical-business-review.com/news/athenex-files-proceedings-chapter-11/ 2023-05-17T11:03:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/testalize-me-0jE8ynV4mis-unsplash.jpg https://www.pharmaceutical-business-review.com/news/melinta-xediton-anti-infective/ 2023-05-18T10:49:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/Bacteriuria_pyuria_4.jpg https://www.pharmaceutical-business-review.com/news/intercept-pharmaceuticals-odd-oca-bezafibrate-pbc/ 2023-05-19T11:12:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/Intercept-17May2023.jpg https://www.pharmaceutical-business-review.com/news/fda-accepts-ardelyxs-nda-resubmission-for-xphozah/ 2023-05-22T07:20:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/Medicines-18May2023.jpg https://www.pharmaceutical-business-review.com/news/nice-recommends-cara-kapruvia/ 2023-05-23T10:49:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/robina-weermeijer-szKjHyPq28-unsplash.jpg https://www.pharmaceutical-business-review.com/news/fda-pfizer-rsv-vaccine/ 2023-05-24T10:19:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/Pfizer.jpg https://www.pharmaceutical-business-review.com/news/rhythm-genpharm-imcivree-gcc-countries/ 2023-05-25T11:06:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/Obesity.jpg https://www.pharmaceutical-business-review.com/news/innoviva-fda-approval-habp-vabp/ 2023-05-26T12:11:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/800px-Streptococcus_pneumoniae_-_A_causative_bacteria_of_meningitis.jpg https://www.pharmaceutical-business-review.com/news/alvotech-advanz-biosimilars-europe/ 2023-05-29T11:00:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/mufid-majnun-TVI5NiTcpOw-unsplash.jpg https://www.pharmaceutical-business-review.com/news/varmx-funds-seek-vmx-c001/ 2023-05-30T10:59:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/anirudh-UiwUtEqROEs-unsplash.jpg https://www.pharmaceutical-business-review.com/news/marinus-pharmaceuticals-positive-opinion-ztalmy-chmp/ 2023-05-31T10:18:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/epilepsy-29May2022.jpg https://www.pharmaceutical-business-review.com/news/abiogen-pharma-stake-effrx-pharmaceuticals/ 2023-06-01T10:29:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/AbiogenPharma-30May2023.jpg https://www.pharmaceutical-business-review.com/news/exmoor-35m-boost-cell-gene-therapy/ 2023-06-02T10:46:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/05/national-cancer-institute-GcrSgHDrniY-unsplash.jpg https://www.pharmaceutical-business-review.com/news/ema-prime-designation-rockets-aav/ 2023-06-05T10:20:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/1200px-Cardiac_surgery_operating_room.jpg https://www.pharmaceutical-business-review.com/news/levolta-tabuk-oa-therapy-in-mea/ 2023-06-06T10:30:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/1200px-Heberden-Arthrose.jpg https://www.pharmaceutical-business-review.com/news/nmpa-btd-olverembatinib-sdh-deficient-gist/ 2023-06-07T10:33:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/olga-guryanova-tMFeatBSS4s-unsplash-1.jpg https://www.pharmaceutical-business-review.com/news/rani-celltrion-partnership-adalimumab-biosimilar/ 2023-06-08T10:54:22+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/national-cancer-institute-DYQfoftWGXw-unsplash-1.jpg https://www.pharmaceutical-business-review.com/news/samsung-biologics-pfizer-biosimilars-manufacturing/ 2023-06-09T10:09:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/Pfizer_World_Headquarters_Entrance.jpg https://www.pharmaceutical-business-review.com/news/janssen-fda-approval-carvykti/ 2023-06-09T10:09:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/Multiple_Myeloma.jpg https://www.pharmaceutical-business-review.com/news/cosette-worldwide-rights-endoceutics-intraros/ 2023-06-13T11:51:50+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/Intrarosa.jpg https://www.pharmaceutical-business-review.com/news/edgecap-partners-buys-comac-medical/ 2023-06-14T11:04:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/EdgeCap.jpg https://www.pharmaceutical-business-review.com/news/charles-river-curigin-partner/ 2023-06-15T11:10:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/julia-koblitz-RlOAwXt2fEA-unsplash.jpg https://www.pharmaceutical-business-review.com/news/eupraxia-ep-104iar-fda-fast-track/ 2023-06-16T09:45:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/knee-2768834_1280.jpg https://www.pharmaceutical-business-review.com/news/fresenius-kabi-vasopressin-us/ 2023-06-19T10:49:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/Vasopressin_FK_63323-930-00_1557_3inw_300dpi-1.jpg https://www.pharmaceutical-business-review.com/news/sandoz-launches-action-plan-to-improve-access-to-biosimilar-medicines/ 2023-06-20T10:38:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/thought-catalog-Q4eWnth5S74-unsplash-1.jpg https://www.pharmaceutical-business-review.com/news/rosemont-acquires-lucis/ 2023-06-21T10:36:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/Lucis-Pharma-Image-Product-Development-1.jpg https://www.pharmaceutical-business-review.com/news/eli-lilly-to-acquire-dice-therapeutics/ 2023-06-22T05:00:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/laurynas-mereckas-1TL8AoEDj_c-unsplash.jpg https://www.pharmaceutical-business-review.com/news/f2g-complete-response-olorofim-nda/ 2023-06-22T05:00:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/1200px-Pulmonary_aspergillosis.jpg https://www.pharmaceutical-business-review.com/news/fda-priority-review-bluebird-bla-scd/ 2023-06-26T12:18:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/blood-g11a608f92_640.jpg https://www.pharmaceutical-business-review.com/news/mpp-shionogi-sublicence-ensitrelvir/ 2023-06-27T11:45:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/coronavirus26June2023.jpg https://www.pharmaceutical-business-review.com/news/biotech-altpep-53m-series-b-funding/ 2023-06-27T11:45:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/robina-weermeijer-3KGF9R_0oHs-unsplash-1-1.jpg https://www.pharmaceutical-business-review.com/news/gsk-daprodustat-positive-opinion/ 2023-06-29T17:14:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/robina-weermeijer-sRXCFkJahGk-unsplash-3-e1687866359137.jpg https://www.pharmaceutical-business-review.com/news/gsk-acquires-bellus-health/ 2023-06-30T08:19:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/GSK-HQ.jpg https://www.pharmaceutical-business-review.com/news/regeneron-response-letter-aflibercept-bla/ 2023-06-30T14:08:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/regeneron-.jpg https://www.pharmaceutical-business-review.com/news/fda-bla-pfizer-haemophilia/ 2023-06-30T14:08:46+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/06/pfizer-logo-1.jpg https://www.pharmaceutical-business-review.com/news/sandoz-biosimilar-humira-us/ 2023-07-05T04:58:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/Rheumatoid_Arthritis.jpg https://www.pharmaceutical-business-review.com/news/fda-clearance-trial-skyline/ 2023-07-06T13:23:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/amanda-dalbjorn-fvInY-Gh7sc-unsplash-4-e1688460332227.jpg https://www.pharmaceutical-business-review.com/news/taihos-lytgobi-tablets-european-authorisation/ 2023-07-07T11:49:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/1200px-Cholangiocarcinoma_-_very_high_mag.jpg https://www.pharmaceutical-business-review.com/news/nmpa-approval-torays-antipruritus/ 2023-07-10T09:50:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/1088px-Dermatitis2015.jpg https://www.pharmaceutical-business-review.com/news/european-commission-full-ma-covid-19/ 2023-07-11T10:03:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/fusion-medical-animation-rnr8D3FNUNY-unsplash-1.jpg https://www.pharmaceutical-business-review.com/news/fda-280bios-ind-yl-17231/ 2023-07-12T11:40:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/laboratory-ge89f49925_640.jpg https://www.pharmaceutical-business-review.com/news/fda-label-update-novartis-leqvio/ 2023-07-13T09:42:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/artur-tumasjan-qLzWvcQq-V8-unsplash-2.jpg https://www.pharmaceutical-business-review.com/news/tga-approval-hansas-idefirix/ 2023-07-14T05:17:26+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/robina-weermeijer-szKjHyPq28-unsplash-1.jpg https://www.pharmaceutical-business-review.com/news/astellas-acquisition-iveric-bio/ 2023-07-17T05:06:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/kindle-g94d575318_640.jpg https://www.pharmaceutical-business-review.com/news/theracosbios-commercialises-type-2-diabetes-oral-tablet/ 2023-07-18T05:12:19+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/Type_2_Diabetes_28081593711.jpg https://www.pharmaceutical-business-review.com/news/fda-approval-veklury-covid-19/ 2023-07-19T08:08:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/Coronavirus_SARS-CoV-2.jpg https://www.pharmaceutical-business-review.com/news/eleven-research-novo-nordisk/ 2023-07-20T10:24:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/cdc-WCEOtVmk2VY-unsplash.jpg https://www.pharmaceutical-business-review.com/news/harrow-buys-rights-santens-ophthalmic/ 2023-07-21T13:30:42+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/ion-fet-QRawWgV6gmo-unsplash.jpg https://www.pharmaceutical-business-review.com/news/biocryst-kim-pharmaceuticals/ 2023-07-24T11:29:27+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/desperate-gc70933d01_640.jpg https://www.pharmaceutical-business-review.com/news/emergent-biosolutions-fda-cyfendus-vaccine/ 2023-07-25T05:07:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/Vaccine-21July2023.jpg https://www.pharmaceutical-business-review.com/news/bristol-myers-positive-opinion-opdivo/ 2023-07-26T11:02:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/laboratory-gbd766958e_640.jpg https://www.pharmaceutical-business-review.com/news/nmpa-biopharmas-bla-zynlonta/ 2023-07-27T07:07:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/lab-gf7f10e0d2_640.jpg https://www.pharmaceutical-business-review.com/news/biovian-turku-manufacturing-unit/ 2023-07-28T09:43:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/biovian.jpg https://www.pharmaceutical-business-review.com/news/ec-astrazeneca-soliris-refractory-gmg/ 2023-07-31T06:16:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/AstraZeneca.jpg https://www.pharmaceutical-business-review.com/news/cell-therapy-kincell-bio/ 2023-07-31T06:17:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/Kincell-Bio.jpg https://www.pharmaceutical-business-review.com/news/fda-rivive-naloxone-nasal-spray/ 2023-08-02T05:46:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/07/Nasal_Spray.jpg https://www.pharmaceutical-business-review.com/news/viatris-kindeva-breyna-asthma-copd/ 2023-08-03T09:29:00+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/Viatris.jpg https://www.pharmaceutical-business-review.com/news/solu-therapeutics-cytac-platform-drug/ 2023-08-04T13:10:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/microscope-g8eb295fe5_1280.jpg https://www.pharmaceutical-business-review.com/news/index-patent-europe-ulcerative/ 2023-08-07T04:17:09+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/1200px-Chronic_active_ulcerative_colitis_intermed._mag.jpg https://www.pharmaceutical-business-review.com/news/agios-alnylam-sirna-candidate/ 2023-08-08T06:41:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/1200px-Red_Blood_Cell.jpg https://www.pharmaceutical-business-review.com/news/sage-biogen-fda-approval-ppd/ 2023-08-09T06:32:54+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/woman.jpg https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-close-japanese-subsidiary/ 2023-08-10T05:21:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/national-cancer-institute-_gAE02nLoWs-unsplash-1.jpg https://www.pharmaceutical-business-review.com/news/amarin-neopharm-vazkepa-israel/ 2023-08-11T06:23:53+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/Kapseln.jpg https://www.pharmaceutical-business-review.com/news/agc-cell-gene-therapy-site-italy/ 2023-08-14T06:49:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/cell-and-gene.jpg https://www.pharmaceutical-business-review.com/news/genprex-orphan-drug-designation-lung-cancer/ 2023-08-15T04:46:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/Lungs.jpg https://www.pharmaceutical-business-review.com/news/novartis-chinook-therapeutics-3-5bn/ 2023-08-16T11:02:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/novartis-pavillon-novartis-campus-banting-1-background.jpg https://www.pharmaceutical-business-review.com/news/eli-lilly-and-company-acquires-versanis-bio/ 2023-08-17T10:20:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/weighing-scale-15Aug2023.jpg https://www.pharmaceutical-business-review.com/news/fda-venatorxs-cefepime-taniborbactam/ 2023-08-18T06:24:13+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/sasun-bughdaryan-xWlsYJU4ynE-unsplash.jpg https://www.pharmaceutical-business-review.com/news/day-one-sprint-bioscience-vrk1/ 2023-08-21T10:06:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/brano-Mm1VIPqd0OA-unsplash.jpg https://www.pharmaceutical-business-review.com/news/abcuro-raises-155m-series-b-autoimmune/ 2023-08-22T05:50:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/Pill-18Aug2023.jpg https://www.pharmaceutical-business-review.com/news/fda-calliditas-tarpeyo-capsules/ 2023-08-23T04:54:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/robina-weermeijer-igwG8aIaypo-unsplash-1.jpg https://www.pharmaceutical-business-review.com/news/canariabio-orphan-drug-designation-cancer/ 2023-08-24T05:27:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/Pancreas_adenocarcinoma.jpg https://www.pharmaceutical-business-review.com/news/ec-cma-janssens-talvey/ 2023-08-25T10:51:30+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/1200px-Multiple_Myeloma.jpg https://www.pharmaceutical-business-review.com/news/fda-priority-review-xtandi/ 2023-08-28T05:28:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/Prostate_cancer_with_Gleason_pattern_4_low_mag-2.jpg https://www.pharmaceutical-business-review.com/news/alentis-ale-c04-fast-track-designation/ 2023-08-29T05:59:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/national-cancer-institute.jpg https://www.pharmaceutical-business-review.com/news/akeso-priority-review-ivonescimab-china/ 2023-08-30T12:33:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/Medicines.jpg https://www.pharmaceutical-business-review.com/news/allucent-expedite-covid-19-booster/ 2023-08-31T10:42:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/coronavirus-4972480_640-1.jpg https://www.pharmaceutical-business-review.com/news/fda-orphan-drug-designation-bexmarilimab/ 2023-09-01T10:57:51+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/Acute_Myelogenous_Leukemia_with_maturation.jpg https://www.pharmaceutical-business-review.com/news/kyowa-kirin-japan-calcimimetics-agent/ 2023-09-04T11:56:01+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/08/approved-1966719_1280.png https://www.pharmaceutical-business-review.com/news/mallinckrodt-approval-lisdexamfetamine-dimesylate/ 2023-09-05T11:31:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/brain-disorder.jpg https://www.pharmaceutical-business-review.com/news/innovac-funding-lead-programmes-development/ 2023-09-06T09:25:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/lead-programme.jpg https://www.pharmaceutical-business-review.com/news/novo-nordisk-wegovy-obese-uk/ 2023-09-07T10:44:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/weighing-scale-7053082_640-2-1.jpg https://www.pharmaceutical-business-review.com/news/maruho-licence-journey-medical-qbrexza/ 2023-09-08T10:38:08+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/Hyperhidrosis_Treatment.jpg https://www.pharmaceutical-business-review.com/news/united-gerd-drug-singapore/ 2023-09-08T10:38:20+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/1200px-Gastroesophageal_reflux_disease_-_glycogen_-_very_high_mag.jpg https://www.pharmaceutical-business-review.com/news/procaps-bdr-agreement-oncology-molecules/ 2023-09-12T10:27:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/Medicines.jpg https://www.pharmaceutical-business-review.com/news/fda-guidance-citius-lymphoma/ 2023-09-13T10:23:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/citius.jpg https://www.pharmaceutical-business-review.com/news/orano-med-orbit-radionuclide-therapies/ 2023-09-14T10:49:57+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/national-cancer-institute-fOLO2hDMsa4-unsplash.jpg https://www.pharmaceutical-business-review.com/news/salipro-sumitomo-drug-discovery/ 2023-09-15T10:46:11+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/Drug-discovery.jpg https://www.pharmaceutical-business-review.com/news/synaffix-abl-bio-develop-bispecific-adcs/ 2023-09-18T03:47:37+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/ADC-drug.jpg https://www.pharmaceutical-business-review.com/news/nona-beigene-antibody-discovery-partnership/ 2023-09-19T11:08:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/syringe-tablet.jpg https://www.pharmaceutical-business-review.com/news/nice-recommends-quviviq-chronic-insomnia/ 2023-09-20T09:09:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/sleep-disorder.jpg https://www.pharmaceutical-business-review.com/news/kymera-fast-track-kt-333/ 2023-09-21T09:01:33+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/Cutaneous_T-cell_lymphoma_-_intermed_mag.jpg https://www.pharmaceutical-business-review.com/news/viiv-healthcare-european-commission-apretude/ 2023-09-22T09:40:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/HIV-virus.jpg https://www.pharmaceutical-business-review.com/news/wuxi-xdc-opens-gmp-facilities-china/ 2023-09-25T09:56:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/Wuxi.jpg https://www.pharmaceutical-business-review.com/news/fda-krystal-kb408-aatd/ 2023-09-26T09:06:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/Alpha-1_antitrypsin_deficiency.PAS_Diastase.jpg https://www.pharmaceutical-business-review.com/news/lupin-five-brands-rights-menarini/ 2023-09-28T08:48:05+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/anxieties-342462_640.jpg https://www.pharmaceutical-business-review.com/news/sanofi-japanese-authorisation-factor-viii-therapy/ 2023-09-28T09:13:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/blood-1813410_1280.jpg https://www.pharmaceutical-business-review.com/news/saptalis-pharmaceuticals-metronidazole-oral-suspension/ 2023-09-29T05:41:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/suspension.jpg https://www.pharmaceutical-business-review.com/news/ideaya-fast-track-breast-cancer-therapy/ 2023-10-02T06:18:18+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/breast-treatment.jpg https://www.pharmaceutical-business-review.com/news/merck-fda-priority-review/ 2023-10-03T09:53:34+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/09/merck1.jpg https://www.pharmaceutical-business-review.com/news/novartis-offloads-ophthalmology-assets/ 2023-10-04T07:11:23+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/novartis-0210.jpg https://www.pharmaceutical-business-review.com/news/cambrex-capacity-high-point-facility/ 2023-10-05T11:50:07+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/High_Point-image.jpg https://www.pharmaceutical-business-review.com/news/bridgebio-and-resilience-partner/ 2023-10-06T11:54:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/BridgeBio.jpg https://www.pharmaceutical-business-review.com/news/shorla-35m-series-b-oncology-portfolio/ 2023-10-09T11:39:43+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/transmission-electron-microscope-2223456_640-1.jpg https://www.pharmaceutical-business-review.com/news/wheeler-bio-drug-substance-cgmp-facility/ 2023-10-10T11:42:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/laboratory-2815641_1920.jpg https://www.pharmaceutical-business-review.com/news/taiwan-can108-cholestatic-pruritus/ 2023-10-11T11:31:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/1200px-Cholestasis_high_mag.jpg https://www.pharmaceutical-business-review.com/news/curasen-funding-advance-cst-3056/ 2023-10-12T11:46:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/robina-weermeijer-3KGF9R_0oHs-unsplash-1.jpg https://www.pharmaceutical-business-review.com/news/y-s-p-industries-market-taigens-new-drug/ 2023-10-13T08:16:35+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/hal-gatewood-nhG5gix93es-unsplash-1.jpg https://www.pharmaceutical-business-review.com/news/fda-kyvernas-scleroderma-therapy/ 2023-10-16T09:31:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/Systemic_sclerosis_changes_on_hands_are_allways_bilateral.jpg https://www.pharmaceutical-business-review.com/news/agc-expansion-pdna-and-mrna/ 2023-10-17T10:54:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/MicrosoftTeams-image-116.jpg https://www.pharmaceutical-business-review.com/news/mercks-keytruda-opinion-chmp/ 2023-10-18T11:52:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/1125px-Adenocarcinoma_low_differentiated_stomach_HE_magn_400x.jpg https://www.pharmaceutical-business-review.com/news/united-medical-approval-minjuvi-brazil/ 2023-10-19T10:06:31+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/Red-approved.gif https://www.pharmaceutical-business-review.com/news/china-accepts-canbridges-nda-for-can108/ 2023-10-20T10:56:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/1200px-Cholestasis_high_mag-1.jpg https://www.pharmaceutical-business-review.com/news/hyloris-maxigesic-iv-approval-pain-management/ 2023-10-23T02:48:59+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/Maxigestic.jpg https://www.pharmaceutical-business-review.com/news/aldena-pci-injectable-dermatological-treatment/ 2023-10-24T10:57:55+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/Syringe.jpg https://www.pharmaceutical-business-review.com/news/nice-recommends-brukinsa-adults-cll/ 2023-10-25T10:22:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/Lyphoma.jpg https://www.pharmaceutical-business-review.com/news/certa-orphan-drug-designation-systemic-sclerosis/ 2023-10-26T11:24:03+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/Systemic_sclerosis.jpg https://www.pharmaceutical-business-review.com/news/caris-moderna-oncology-therapeutics-advancement/ 2023-10-27T11:20:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/mRNA-.jpg https://www.pharmaceutical-business-review.com/news/mithra-license-searchlight-donesta-canada/ 2023-10-30T09:56:45+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/women.jpg https://www.pharmaceutical-business-review.com/news/thermogenesis-cell-gene-therapy-sacramento/ 2023-10-31T11:13:10+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/Gene-therapy.jpg https://www.pharmaceutical-business-review.com/news/canadas-pharmadrug-acquire-securedose-synthetics/ 2023-11-01T10:58:25+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/Pharmadrug.jpg https://www.pharmaceutical-business-review.com/news/basilea-intron-deal-antibacterial-agent/ 2023-11-02T11:19:29+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/10/lab-bacteria.jpg https://www.pharmaceutical-business-review.com/news/altasciences-laboratory-facility-expansion/ 2023-11-03T11:41:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/Altasciences_Columbia_Lab.jpg https://www.pharmaceutical-business-review.com/news/prelude-partnership-abcellera-oncology/ 2023-11-06T11:37:14+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/Research.jpg https://www.pharmaceutical-business-review.com/news/noramco-drug-product-business-unit-cambrex/ 2023-11-07T09:33:24+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/drug-formulation.jpg https://www.pharmaceutical-business-review.com/news/mirati-approval-uks-mhra-nsclc-therapy/ 2023-11-08T11:33:39+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/NSCLC.jpg https://www.pharmaceutical-business-review.com/news/halozyme-acumen-enhanze-drug-delivery/ 2023-11-09T10:35:40+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/enzyme-tech.jpg https://www.pharmaceutical-business-review.com/news/orsobio-treatment-obesity-associated-disorders/ 2023-11-10T08:02:52+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/obesity.jpg https://www.pharmaceutical-business-review.com/news/juventas-nmpa-approval-cell-therapy/ 2023-11-13T00:38:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/Juventas-.jpg https://www.pharmaceutical-business-review.com/news/valneva-austria-fda-chikungunya/ 2023-11-14T04:22:02+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/Chikungunya.jpg https://www.pharmaceutical-business-review.com/news/lipella-pharmaceuticals-odd-lp-310-gvhd/ 2023-11-15T10:33:32+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/Medicine-13Nov2023.jpg https://www.pharmaceutical-business-review.com/news/otsuka-pharmaceutical-nda-voclosporin/ 2023-11-16T11:16:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/Lupus_Nephritis.jpg https://www.pharmaceutical-business-review.com/news/kesin-pharma-approval-fda-likmez/ 2023-11-17T11:26:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/Bottle.jpg https://www.pharmaceutical-business-review.com/news/xentria-odd-anti-tnf%ce%b1-monoclonal-antibody/ 2023-11-20T11:20:49+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/Tna-inhinotor.jpg https://www.pharmaceutical-business-review.com/news/q32-bio-merge-homology-medicines/ 2023-11-21T11:10:58+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/Homology.jpg https://www.pharmaceutical-business-review.com/news/almirall-approval-atopic-dermatitis-therapyx/ 2023-11-22T10:57:48+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/Atopic-dermatis.jpg https://www.pharmaceutical-business-review.com/news/neoimmunetech-orphan-drug-status-nt-i7/ 2023-11-23T10:51:56+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/logan-moreno-gutierrez-Rl9bIWKCVF0-unsplash.jpg https://www.pharmaceutical-business-review.com/news/beigene-global-license-ensem-therapeutics/ 2023-11-24T11:12:16+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/Research-1.jpg https://www.pharmaceutical-business-review.com/news/us-fda-valnevas-vaccine-chikungunya/ 2023-11-27T11:45:47+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/ekamelev-sZIjgg4Peu0-unsplash.jpg https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-acquisition-t3-pharmaceuticals/ 2023-11-28T11:08:17+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/Multiple_myeloma.jpg https://www.pharmaceutical-business-review.com/news/mesoblast-applications-fda-hlhs-therapy/ 2023-11-29T10:40:04+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/heart-disease.jpg https://www.pharmaceutical-business-review.com/news/sernova-odd-rpdd-haemophilia-a-programme/ 2023-11-30T08:34:12+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/blood-clot.jpg https://www.pharmaceutical-business-review.com/news/evommune-accutar-chronic-inflammatory-diseases/ 2023-12-01T11:58:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/therapy-discovery.jpg https://www.pharmaceutical-business-review.com/news/us-fda-karunas-nda-schizophrenia-therapy/ 2023-12-04T11:02:21+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/11/schizophrenia-30November-2023.jpg https://www.pharmaceutical-business-review.com/news/phenomic-astellas-solid-tumour-cell-therapies/ 2023-12-05T11:13:38+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/12/solid-tumour.jpg https://www.pharmaceutical-business-review.com/news/abbvie-acquire-immunogen-10-1bn/ 2023-12-06T14:08:06+00:00 https://www.pharmaceutical-business-review.com/wp-content/uploads/2023/12/Pill-4Dec2023.jpg